Page last updated: 2024-08-23

etoposide and Disease Exacerbation

etoposide has been researched along with Disease Exacerbation in 319 studies

Research

Studies (319)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	51 (15.99)	18.2507
2000's	145 (45.45)	29.6817
2010's	107 (33.54)	24.3611
2020's	16 (5.02)	2.80

Authors

Authors	Studies
Blackhall, F; Bratt, S; Brown, S; Chaturvedi, A; Descamps, T; Dive, C; Frese, KK; Galvin, M; Greenhalgh, M; Hossain, ASMM; Humphrey, S; Kerr, A; Lallo, A; Pearce, SP; Pearsall, S; Priest, L; Revill, M; Schenk, MW; Zhou, C	1
Akagi, K; Dotsu, Y; Fukuda, M; Gyotoku, H; Hayashi, F; Hisamatsu, Y; Ikeda, T; Kinoshita, A; Morinaga, R; Mukae, H; Nagashima, S; Nakatomi, K; Ogata, R; Ono, S; Senju, H; Shimada, M; Soda, H; Sugasaki, N; Tagawa, R; Takemoto, S; Taniguchi, H; Tomono, H; Umeyama, Y	1
Chargari, C; Coppin, R; Faure-Conter, C; Fresneau, B; Guérin, F; Martelli, H; Orbach, D; Pasquet, M; Patte, C; Piguet, C; Saumet, L; Sudour-Bonnange, H; Vérité, C	1
Guo, L; Guo, Y; Huang, W; Li, M; Liang, S; Peng, J; Wang, Q; Wang, S; Zeng, F; Zhu, W	1
Alejos, A; Amador, G; Barnoya, M; Castellanos, ME; Chantada, G; Fu, L; Fuentes-Alabi, S; Girón, V; Goenz, MA; Luna-Fineman, S; Maldonado, C; Méndez, G; Morales, RA; Ortiz, R; Rodríguez-Galindo, C; Sanchez, G; Wilson, M	1
Albert, DM; Ali, MJ; Chévez-Barrios, P; Chintagumpala, M; Eagle, RC; Gao, Y; Honavar, SG; Khetan, V; Krailo, M; Leahey, AM; Matthay, K; Meadows, A; O'Brien, J; Piao, J; Vemuganti, G	1
Gunturu, KS; Ho, D; Raibagkar, P; Srinivasan, J	1
Borok, M; Campbell, TB; Caruso, S; Dittmer, DP; Godfrey, C; Hoagland, B; Hosseinipour, MC; Kang, M; Krown, SE; Martinez-Maza, O; Mngqibisa, R; Mwelase, N; Ngongondo, M; Nyirenda, M; Samaneka, W; Umbleja, T	1
Balakrishnan, A; Kumar, P; Prasanna, BK	1
Baumann, T; Caballero, AC; Canet, M; Escoda, L; García, O; Iserte, L; López-Guillermo, A; Magnano, L; Mercadal, S; Muntañola, A; Salar, A; Sánchez-González, B; Sancho, JM; Soler, A; Sorigué, M; Villalobos, MT	1
André, MPE; Bellei, M; Brice, P; Brière, J; Carde, P; Casasnovas, O; Clément-Filliatre, L; Depaus, J; Douxfils, J; Dupuis, J; Federico, M; Fortpied, C; Gianni, AM; Gobbi, PG; Heczko, M; Hutchings, M; Iannitto, E; Mounier, N; Rambaldi, A; Valagussa, P; Viviani, S; Zinzani, PL	1
Lomma, C; Ransom, D	1
Behrens, YL; Ganser, A; Göhring, G; Kreipe, HH; Schünemann, C; Thol, F	1
Adam, J; Bayle, A; Briand, S; Chamseddine, AN; Court, C; Dômont, J; Dumont, SN; Even, C; Faron, M; Haddag-Miliani, L; Honoré, C; Lazure, T; Le Cesne, A; Levy, A; Lucibello, F; Mir, O; Ngo, C; Perret, A; Verret, B	1
Lovetrue, B	1
Nogalski, MT; Shenk, T	1
Bruce, JN; Canoll, PD; Englander, ZK; Feldstein, NA; Guo, J; Jan, CI; Konofagou, EE; Mela, A; Pouliopoulos, AN; Upadhyayula, PS; Wang, TJC; Wei, HJ; Wu, CC; Zacharoulis, S; Zhang, X; Zhang, Z	1
Alatorre-Alexander, J; Califano, R; Cheng, Y; De Castro Carpeno, J; Deng, Y; Garassino, MC; Horn, L; Lam, S; Leal, T; Lee, JS; Liu, SV; Mansfield, AS; McCleland, M; Mok, T; Nishio, M; Orlandi, F; Phan, S; Reck, M; Reinmuth, N; Scherpereel, A	1
Li, C; Li, W; Su, Z; Zhang, J; Zhang, X	1
Agarwala, S; Bakhshi, S; Batra, A; Dhawan, D; Gupta, YK; Pramanik, R; Thulkar, S; Vishnubhatla, S	1
Balakrishnan, VS	1
Brillant, C; Engert, A; Monsef, I; Skoetz, N; von Tresckow, B; Will, A	1
Akeno, N; Callahan, M; He, D; Kim, RG; Lane, A; Miller, AL; Moulton, JS; Reece, AL; Wikenheiser-Brokamp, KA	1
Jaffe, ES; Lucas, A; Melani, C; Pittaluga, S; Roschewski, M; Roswarski, J; Steinberg, SM; Waldmann, TA; Wilson, WH	1
Costa, JC; Grauslund, M; Melchior, LC; Santoni-Rugiu, E; Sørensen, JB; Urbanska, EM	1
Andritsos, LA; Awan, FT; Byrd, JC; Flynn, JM; Heerema, NA; Huang, Y; Jones, JA; Maddocks, KJ; Rogers, KA; Ruppert, AS; Salem, G; Stephens, DM	1
Clamp, AR; Hasan, J; Jayson, GC; Mescallado, N; Mitchell, C; Morgan, RD; Saunders, G; Welch, R	1
Moeller, M; Schuette, W; Siebolts, U; Wickenhauser, C	1
Amaki, J; Asano, N; Choi, I; Ejima, Y; Fukuhara, N; Katayama, N; Kim, SJ; Kim, WS; Ko, YH; Kobayashi, Y; Kubota, N; Maeda, T; Miyazaki, K; Oguchi, M; Saito, B; Shimada, K; Shimoda, E; Soejima, T; Suzuki, R; Terui, Y; Tsukamoto, N; Utsumi, T; Yamaguchi, M	1
Chen, J; Chen, X; Gao, J; Guan, YY; Ke, K; Li, M; Liu, XL; Wang, YC; Wu, XM; Yang, F; Yang, XY; Yao, JF; Zhang, CL; Zheng, YS	1
Chang, J; Hao, SG; Li, GY; Li, ZC; Ma, YJ; Tao, R; Zhang, WH; Zhu, Y	1
Hamada, N; Nakanishi, Y; Okamoto, I; Otsubo, K	1
Cuadra, M; Lapuente-Ocamica, O; Lete, I; Lopez-Picado, A; Maestro, L; Ugarte, L	1
Feng, YL; Huang, HQ; Huang, X; Lan, CY; Li, JD; Li, YF; Liu, Q; Shen, JX; Wang, Y; Xiong, Y; Zhang, YN; Zheng, M	1
Ismail, H; Khan, RS; Saba, A	1
Kasami, T; Kawamoto, K; Kiryu, M; Miyoshi, H; Ohshima, K; Sone, H; Suzuki, T; Takizawa, J	1
Dean, S; Herath, D; Kosmider, S; McCracken, J	1
Blackhall, F; Faivre-Finn, C; Hatton, M; Locke, I; Mistry, H; Monnet, I; Salem, A	1
Nazha, B; Owonikoko, TK	1
Bishton, M; Campbell, R; Cheah, CY; Cochrane, T; De Mel Widanalage, S; Gilbertson, M; Hapgood, G; Hawkes, E; Hill, K; Johnston, A; Lee, HP; Manos, K; Nelson, N; Ng, M; Ng, ZY; Opat, S; Poon, M; Purtill, D; Ratnasingam, S; Ritchie, D; Schwarer, A; Seymour, J; Shorten, S; Sunny, T; Tam, C; Xin, L	1
Belada, D; Bortlicek, Z; Campr, V; Chloupkova, R; Duras, J; Hamouzova, J; Janikova, A; Klener, P; Kopalova, N; Mayer, J; Mocikova, H; Pirnos, J; Prochazka, V; Pytlik, R; Trneny, M	1
Chi, SG; Kim, HJ; Lee, CK; Moon, JR; Oh, SJ	1
Bahlis, NJ; Daly, A; Duan, Q; Duggan, P; Henning, JW; Shafey, M; Stewart, DA; Vijay, A	1
Bauer, D; Biassoni, V; Casanova, M; Catania, S; De Pava, MV; Gandola, L; Indini, A; Massimino, M; Modena, P; Pecori, E; Podda, M; Polastri, D; Rampini, P; Schiavello, E	1
Bornfeld, N; Eggert, A; Jurklies, C; Künkele, A; Lohmann, D; Schulte, JH; Wieland, R	1
Go, A; Guo, R; Parthasarathy, M; Rodriguez, T; Smith, S; Sobol, U; Stiff, P; Vimr, R	1
Fernández-Sojo, J; Oliveras Vilà, T; Ribera, JM; Vives, S	1
Abdulrezzak, U; Cetin, M; Kaynar, L; Keklik, M; Kontas, O; Sivgin, S	1
Bacci, G; Caputo, R; Cardellicchio, S; de Martino, M; Farina, S; Genitori, L; Massimino, M; Sardi, I	1
Elfers, EE; Grunblatt, E; Hildeman, DA; Jordan, MB; Katz, JD; McNally, JP; Terrell, CE	1
Balleisen, L; Basara, N; Behre, G; Casper, J; Christopeit, M; Ganser, A; Hinke, A; Hinke, R; Kahl, C; Koenigsmann, M; Metzner, B; Mohren, M; Niederwieser, D; Reichle, A; Sayer, HG; Stadler, M; Theurich, S; Uharek, L	1
Hatta, Y; Hirabayashi, Y; Hojo, A; Horikoshi, A; Iriyama, N; Kiso, S; Kobayashi, S; Kobayashi, Y; Kodaira, H; Kura, Y; Kurita, D; Kusuda, M; Miura, K; Nakagawa, M; Sawada, U; Sugitani, M; Takahashi, H; Takei, M; Takeuchi, J; Uchino, Y; Yagi, M	1
Imamura, Y	1
Chen, X; Dai, H; Qian, Z; Wang, Y; Xu, X; Zhao, Y	1
Belada, D; Berková, A; Bolomská, I; Burešová, L; Campr, V; Klener, P; Kozák, T; Kubáčková, K; Matuška, M; Pirnos, J; Přibylová, J; Pytlík, R; Sýkorová, A; Trněný, M; Vášová, I	1
Buil-Bruna, N; López-Picazo, JM; Martín-Algarra, S; Moreno-Jiménez, M; Ribba, B; Trocóniz, IF	1
Karangelis, D; Nikolaidis, N; Roubelakis, A; Weeden, DF	1
Cafferty, FH; Cullen, MH; Gabe, R; Huddart, RA; Pollock, P; Shamash, J; Stenning, SP; White, JD	1
Géczi, L; Küronya, Z; Németh, H	1
Cai, L; Du, J; Li, W; Ma, X; Zhang, J	1
Cai, XW; Fan, M; Fu, XL; Hong, LZ; Liu, Q; Mao, JF; Wu, KL; Xia, B; Yang, HJ; Zhao, KL; Zhu, ZF	1
Barriere, J; Borchiellini, D; Boscagli, A; Coso, D; Garnier, G; Gastaud, L; Gutnecht, J; Martin, N; Naman, H; Petit, E; Peyrade, F; Re, D; Rossignol, B; Saudes, L; Thyss, A	1
Bulanov, A; Chekini, D; Fedyanin, M; Figurin, K; Garin, A; Sekhina, O; Tjulandin, S; Tjulandina, A; Tryakin, A; Vybarava, A	1
Ala, U; Berger, AH; Carver, BS; Castillo-Martin, M; Chen, M; Cordon-Cardo, C; Guarnerio, J; Hobbs, RM; Ishikawa, T; Lunardi, A; Montironi, R; Nardella, C; Ng, C; Pandolfi, PP; Poliseno, L; Quarantotti, V; Seitzer, N; Signoretti, S; Taulli, R; Varmeh, S	1
Chen, P; Chen, Z; Guo, S; Hu, C; Huang, C; Li, B; Li, L; Li, W; Liao, M; Lu, S; Luo, Y; Song, X; Wu, G; Xu, L; Yu, Y; Zhang, L; Zhang, Y; Zhou, C	1
Ayala, AG; Choi, EK; Divatia, M; Miles, BJ; Okoye, E; Ro, JY	1
Barlesi, F; Barre, P; Chatellain, P; Dayen, C; Derollez, M; Fournel, P; Herman, D; Jeannin, G; Lamy, PJ; Langlais, A; Lavole, A; Le Caer, H; Molinier, O; Morin, F; Moro-Sibilot, D; Mourlanette, P; Oster, JP; Pujol, JL; Quoix, E; Renault, A; Souquet, PJ; Zalcman, G	1
Costa, DB; Desai, NV; Folch, E; Gangadharan, SP; Huberman, MS; Karp, RS; Kent, MS; Le, X; Majid, A; Rangachari, D; VanderLaan, PA	1
Ganesan, P; Ganesan, TS; Kannan, K; Krishnakumar, R; Lakshmipathy, KM; Mahajan, V; Radhakrishnan, V; Rajaraman, S; Rajendranath, R; Sagar, TG; Sundersingh, S; Udupa, K	1
Komune, S; Nakashima, T; Toh, S; Yamauchi, M; Yasumatsu, R	1
Adachi, J; Fujimaki, T; Fukuoka, K; Matsutani, M; Mishima, K; Nishikawa, R; Shirahata, M; Suzuki, T; Yanagisawa, T	1
Baggstrom, M; Bogart, J; Crawford, J; Graziano, SL; Gu, L; Masters, GA; Miller, AA; Otterson, GA; Pang, HH; Ready, NE; Thomas, SP; Vokes, EE	1
Akinaga, S; Fujiwara, H; Imada, K; Ishida, T; Ishitsuka, K; Jo, T; Miyamoto, T; Moriuchi, Y; Nosaka, K; Saburi, Y; Suzushima, H; Taira, N; Takemoto, S; Tobinai, K; Tomonaga, M; Ueda, R; Uike, N; Uozumi, K; Utsunomiya, A; Yamamoto, K; Yoshida, S	1
Baldi, L; Boni, C; Braglia, L; Gnoni, R; Pagano, M; Savoldi, L; Zanelli, F	1
Cai, J; Dai, H; Di, L; Hong, R; Li, L; Wan, D; Xu, B; Yan, M; Yuan, P; Zhang, X; Zhang, Y; Zhu, Q	1
Abdullah, A; Branick, KA; Freeling, JL; Rezvani, K; Sane, S; Wang, H; Zhang, D	1
Dobelbower, M; Donavanik, V; Gomella, L; Grignon, D; Hamstra, DA; Hartford, AC; Hunt, D; Jones, CU; Kerlin, KJ; Kim, H; Kuban, DA; Michalski, J; Moughan, J; Pienta, KJ; Rajan, R; Rosenthal, SA; Rotman, M; Sandler, H; Sartor, AO; Seider, M; Shipley, WU; Zeitzer, K	1
Agerbaek, M; Bandak, M; Daugaard, G; Gupta, R; Holm, NV; Kier, MG; Lauritsen, J; Mortensen, MS	1
Asara, JM; Beck, AH; Cheng, L; Dai, X; Gan, W; Huang, J; Inuzuka, H; Li, Z; Liu, P; Lunardi, A; Pandolfi, PP; Sun, Y; Varmeh, S; Wei, W; Zhang, J	1
Eisele, G; Roth, P; Tonder, M; Weller, M	1
Anderson, JR; Arndt, CA; Hawkins, DS; Lyden, E; Meyer, WH; Michalski, JM; Parham, DM; Rodeberg, DA; Weigel, BJ	1
Abaza, H; Ben Chaabene, A; Boussen, H; Guemira, F; Rahal, K; Sallami, S	1
Fujisawa, S; Hagihara, M; Ishii, Y; Itabashi, M; Matsumoto, K; Motohashi, K; Numata, A; Yamamoto, W	1
Briones, J; Cantalapiedra, A; Díaz-López, A; Domingo-Domenech, E; Espeso, M; García, JF; García-Sanz, R; Jiménez, MJ; López, FJ; Martínez, C; Pérez-Ceballos, E; Rodriguez, MJ; Rodriguez-Calvillo, M; Sampol, A; Sureda, A; Terol, MJ	1
Bae, SH; Eom, HS; Hong, J; Jeong, SH; Kang, HJ; Kim, SJ; Kim, WS; Kwak, JY; Lee, H; Lee, JH; Lee, MH; Park, SK; Shin, DY; Suh, C; Yang, DH; Yhim, HY; Yoon, DH	1
Guarino, M; Hanna, N; Jayaram, N; Masters, GA; Misleh, J; Patel, JD; Sanborn, RE; Stephens, A; Wu, J	1
Beyer, J; Lorch, A	1
Fujimoto, S; Imai, H; Kaira, K; Kazama, T; Minato, K; Mori, K; Watase, N; Yamada, M	1
Balzarotti, M; Cabrera, ME; Ceriani, L; Chiappella, A; Cunningham, D; Ferreri, AJ; Giovanella, L; Gospodarowicz, MK; Guarini, A; Johnson, PW; Martelli, M; Ricardi, U; Stelitano, C; Zinzani, PL; Zucca, E	1
Barbolosi, D; Barlesi, F; El Cheikh, R; Faivre, C	1
Azuma, M; Goto, H; Hanibuchi, M; Kakiuchi, S; Kawano, H; Nishioka, Y; Ogushi, F; Otsuka, K; Saijo, A; Sakaguchi, S; Tezuka, T; Toyoda, Y	1
Fareau, GG; Lopez, A; Stava, C; Vassilopoulou-Sellin, R	1
Artal-Cortes, A; Barneto, I; Camps, C; Carrato, A; Gómez-Codina, J; González-Larriba, JL; Isla, D; Rosell, R; Safont, MJ; Sirera, R	1
Boyett, JM; Dhall, G; Dunkel, IJ; Finlay, JL; Gardner, SL; Goldman, S; Packer, RJ; Pollack, IF; Rosenblum, MK; Stanley, P; Wallace, D; Yates, AJ; Zimmerman, RA	1
Anders, K; Gottlieb, K; Kaya, H	1
Chamberlain, MC; Glantz, MJ	1
Dedeckova, K; Dietlein, M; Eich, HT; Engert, A; Klaskova, K; Kobe, C; Kozak, T; Markova, J; Plütschow, A; Skopalova, M	1
Amaro, T; Arúajo, AM; Azevedo, I; Barata, F; Coelho, AL; Figueiredo, A; Mendez, JC; Soares, M; Sousa, B	1
Kakavelas, P; Kontakiotis, T; Lithoxopoulou, H; Mylonaki, E; Rapti, E; Tsiouda, T; Zarogoulidis, K; Zarogoulidis, P; Zarogoulidou, V	1
Bao, QL; Chen, P; Dai, CH; Li, J; Li, XQ	1
Grossman, ME; Husain, S; MacGregor-Cortelli, B; Marneros, AG; Neylon, E; Nuovo, GJ; O'Connor, OA; Patterson, M; Silvers, DN; Zain, JM	1
Hansen, KH; Hansen, O; Sørensen, P	1
Aoki, T; Matsutani, M; Miyatake, S; Mizutani, T; Nojima, K; Nozaki, K; Okumura, R; Takagi, T; Takahashi, JA; Taki, W; Ueba, T; Yuba, Y	1
Kanemoto, M; Karahashi, T; Kato, T; Kobayashi, C; Morita, S; Tanabe, J	1
Conrad, AL; Go, RS	1
Esparza, J; Hinojosa, J; Iglesias, S; Muñoz, MJ; Otero-Rodríguez, A; Ricoy, JR; Rodríguez-Gil, Y	1
Egerer, G; Ho, AD; Kasper, B; Schmitt, T; Wuchter, P	1
Capasso, I; Comella, G; Comella, P; D'Aiuto, G; D'Aiuto, M; Di Bonito, M; Frasci, G; Iodice, G; Lastoria, S; Montella, M; Oliviero, P; Petrillo, A; Ruffolo, P; Santangelo, M; Siani, C; Vizioli, L	1
Musallam, KM; Taher, AT	1
Culligan, D; Jackson, GH; Jones, GL; Lennard, AL; Lewis, J; Lucraft, HH; McKay, P; Proctor, SJ; Sieniawski, M; White, J; Wilkinson, J	1
Aboulafia, D; Ambinder, RF; Cesarman, E; Chadburn, A; Dezube, BJ; Henry, DH; Kaplan, LD; Lee, JY; Leichman, L; Levine, AM; Mitsuyasu, R; Noy, A; Ramos, JC; Ratner, L; Remick, SC; Shah, MH; Sparano, JA; Von Roenn, J; Wachsman, W	1
Eaton, JW; Grizzle, WE; Novakovic, KR; Sharma, PK; Singh, R; Singh, S	1
Le Péchoux, C; Paumier, A	1
Agelaki, S; Agelidou, A; Agelidou, M; Androulakis, N; Baka, S; Georgoulias, V; Gerogianni, A; Kalbakis, K; Kotsakis, A; Mavroudis, D; Papakotoulas, P; Pavlakou, G; Tsaroucha, E; Vamvakas, L; Veslemes, M	1
Kivivuori, SM; Lönnqvist, T; Riikonen, P; Saarinen-Pihkala, UM; Valanne, L	1
Esiashvili, N; Flowers, C; Kahn, S; Xu, Z	1
Nakamine, H; Nakamura, N; Nakamura, S; Niitsu, N; Ohshima, K; Okamoto, M; Tamaru, J; Yoshino, T	1
Ashcroft, L; Blackhall, F; Califano, R; Colaco, R; Faivre-Finn, C; Lorigan, P; Sheikh, H; Taylor, P; Thatcher, N	1
Busch, C; Knappskog, S; Oberg, K; Sebjornsen, S; Sorbye, H; Welin, S	1
Ganser, A; Göhring, G; Hofmann, W; Lehmann, U; Luna, JC; Manukjan, G; Otto, N; Scherer, R; Schlegelberger, B; Steinemann, D; Welte, K	1
Bower, M; Gazzard, B; Lee, B; Merchant, S; Naresh, K; Nelson, M; Newsom-Davis, T; Stebbing, J	1
Delioukina, M; Forman, SJ; Gaal, K; Kogut, N; Nademanee, A; O'Donnell, M; Palmer, JM; Popplewell, L; Senitzer, D; Thomas, S; Tsai, NC; Zain, J	1
Cyriac, S; Rajendranath, R; Sagar, TG; Sridevi, V	1
Altena, R; Boezen, HM; de Boer, RA; de Vries, EG; Gietema, JA; Hummel, YM; Lefrandt, JD; Nuver, J; Smit, AJ; van den Berg, MP; Voors, AA	1
Johnson, PW; Lim, SH	1
Cox, JD; Curran, WJ; Gore, E; Hauser, S; Komaki, R; Langer, CJ; Lee, JS; Machtay, M; Movsas, B; Paulus, R; Rosenthal, SA; Sause, W; Wasserman, T	1
Aurlien, E; Blystad, AK; Fiskvik, IH; Fosså, A; Hole, KH; Holte, H; Ikonomou, IM; Kolstad, A; Lauritzsen, GF	1
Borchmann, P; Diehl, V; Engert, A	1
Raveesunthornkiet, M; Ruangtrakool, R; Sanpaki, K; Thorner, PS; Treetipsatit, J	1
Bruessow, C; Gubler, J; Karrer, U; Pless, M	1
Dosal, J; Handler, MZ; Kerdel, FA; Ricotti, CA; Tosti, A; Vega, J	1
Anderson, H; Brown, P; d'Amore, F; Delabie, J; Erlanson, M; Fagerli, UM; Gadeberg, OV; Hagberg, H; Holte, H; Jantunen, E; Kuittinen, O; Lauritzsen, GF; Merup, M; Österborg, A; Ralfkiaer, E; Relander, T; Sundström, C; Toldbod, HE; Vornanen, M; Østenstad, B	1
Couvelard, A; de Gramont, A; Faivre, S; Hammel, P; Neuzillet, C; Raymond, E; Serova, M; Tijeras-Raballand, A	1
Bootsma, G; Borger, J; De Ruysscher, D; Dingemans, AM; Geraedts, W; Lambin, P; Lunde, R; Pitz, C; Reymen, B; van Baardwijk, A; Van Loon, J; Wanders, R	1
Cheng, AL; Huang, HC; Kuo, SH; Lin, CW	1
Dickie, G; Finnigan, R; Hruby, G; Keller, J; Poulsen, M; Rischin, D; Tripcony, L; Wratten, C	1
Fujii, M; Goto, H; Ideguchi, M; Nomura, S; Sadahiro, H; Sugimoto, K; Suzuki, M; Yoshikawa, K	1
Jeremić, B; Miličić, B; Milisavljević, S	1
Daliani, DD; Logothetis, CJ; Papandreou, CN; Reyes, A; Thall, PF; Troncoso, P; Tu, SM; Wang, X	1
Badros, A; Barlogie, B; Morris, C; Tricot, G; Zangari, M	1
Byrne, J; Carter, GI; Craddock, CF; Cull, GM; Garg, M; Haynes, AP; Lui Yin, JA; Lush, RJ; Mahendra, P; Mufti, G; Pagliuca, A; Parker, JE; Potter, MN; Prentice, HG; Russell, NH	1
Agelidou, M; Ferdoutsis, E; Georgoulias, V; Kalbakis, K; Kouroussis, Ch; Magkanas, E; Mavroudis, D; Samonis, G; Souglakos, J; Toumbis, M; Tselepatiotis, E; Tzanakis, N; Veslemes, M; Ziotopoulos, P	1
Carcao, M; King, SM; Sung, L; Trebo, M; Weitzman, SS	1
Gennatas, K; Kosmas, C; Kouraklis, G; Margaris, E; Papastratis, G; Rokana, S; Skopelitis, E; Tsavaris, N; Vadiaka, M; Xila, V; Zografos, G	1
Hosoi, H; Iehara, T; Misawa, A; Sawada, T; Sugimoto, T; Tsuchiya, K	1
Baujan, MA; Bourekas, EC; Chakeres, DW; Christoforidis, GA; Newton, HB; Slivka, MA; Slone, W; Volpi, C	1
Dickman, PS; Donaldson, SS; Fryer, CJ; Gebhardt, MC; Grier, HE; Krailo, MD; Link, MP; Meyers, PA; Miser, JS; Moore, S; Perlman, EJ; Pritchard, DJ; Rausen, AR; Tarbell, NJ; Vietti, TJ	1
Billmire, D; Colombani, P; Cushing, B; Davis, M; Giller, R; Hawkins, E; Lauer, S; London, WB; Rescorla, F; Vinocur, C	1
Boissevain, F; Bredenfeld, H; Diehl, V; Eich, H; Engert, A; Franklin, J; Josting, A; Koch, P; Koch, T; Müller-Hermelink, HK; Naumann, R; Paulus, U; Reineke, T; Rueffer, U; Sieber, M; Soekler, M; Wolf, J; Worst, P	1
Lauterbach, I; Mann, G; Niemeyer, C; Parwaresch, R; Reiter, A; Riehm, H; Schrappe, M; Seidemann, K; Simonitsch, I; Stankewitz, K; Tiemann, M; Zimmermann, M	1
Chay, CH; Dunn, RL; Esper, P; Fardig, J; Olson, K; Pienta, KJ; Smith, DC	1
Bonner, JA; Brindle, J; Geyer, SM; Jatoi, A; Jett, JR; Mailliard, JA; McGinnis, WL; Schild, SE; Stella, PJ	1
Bonnet, R; Deppermann, KM; Gatzemeier, U; Hessler, S; Kaukel, E; Macha, HN; Reck, M; Ulm, K; von Pawel, J	1
Goto, K; Ishii, G; Kakinuma, R; Kubota, K; Nagai, K; Niho, S; Nishiwaki, Y; Ohmatsu, H; Suga, M; Yoh, K	1
Gorlick, R; Healey, JH; Huvos, AG; Kolb, EA; Kushner, BH; LaQuaglia, MP; Laverdiere, C; Meyers, PA; Qin, J; Vu, HT; Wexler, L; Wolden, S	1
Ahn, YC; Im, YH; Jung, CW; Kang, WK; Kim, H; Kim, K; Lee, KE; Lee, MH; Lee, SH; Lim, DH; Park, J; Park, K; Park, SH	1
Braybrooke, JP; Davis, T; Harris, AL; Joel, S; Levitt, NC; Madhusudan, S; Talbot, DC; Turley, H; Wilner, S	1
Gude, RP; Nagarsenker, MS; Rao, SG; Sant, VP	1
Davidson, KL; Devaney, MB; Dunlop, DJ; Johnson, PR; Mackie, MJ; Rogers, SY; Thomas, RV; Tighe, JE	1
Abrey, LE; DeAngelis, LM; Lai, R; Rosenblum, MK	1
Ayan, I; Görgün, O; Kebudi, R	1
Feller, AC; Glass, B; Hasenclever, D; Hossfeld, DK; Kloess, M; Loeffler, M; Metzner, B; Pfreundschuh, M; Reiser, M; Rübe, C; Rudolph, C; Schmits, R; Schmitz, N; Trümper, L	1
Elinder, G; Kimby, E; Sverrisdottir, A	1
Richter, P; Solecki, R; Szura, M; Zajac, A	1
Kishida, T; Komiyama, M; Mori, T; Noguchi, M; Noguchi, Y; Ohnishi, M; Sawaguchi, K; Yabushita, H	1
Holte, H; Jerkeman, M; Kvaløy, S; Leppä, S	1
Caballero, MD; Cañizo, MC; López-Holgado, N; Martín, A; Mateos, MV; Miguel, JF; Pérez-Simón, JA	1
Kawaguchi, T; Kumabe, T; Tominaga, T; Watanabe, M	1
deVere White, RW; Ellison, LM; Gandour-Edwards, R; Goldberg, Z; Karpman, E; Saffarian, A	1
Aloulou, S; Cainap, C; Carde, P; Chalhoub, B; Fermé, C; Jabbour, E; Ribrag, V; Suzan, F; Toumi, N	1
Acquatella, G; Carneiro, M; García, R; Gómez, R; Hernández, M; Insausti, CL; Nouel, A; Santos, S	1
Buller, RE; Geisler, JP; Lush, R; Sanders, L; Shahin, MS; Sood, AK; Sorosky, JI; Sullivan, D	1
Delarue, R; Delmer, A; Hermine, O; Lefrère, F; Levy, V; Varet, B	1
Herzog, TJ	1
Aravantinos, G; Bamias, A; Dimopoulos, MA; Efstathiou, E; Gika, D; Hamilos, G; Kalofonos, H; Kouroussis, C; Papadimitriou, C; Rodolakis, A; Skarlos, D; Vlahos, G	1
Aydin, F; Bektas, O; Kavgaci, H; Ozdemir, F; Yavuz, AA; Yavuz, MN; Yilmaz, M	1
Chi, SN; Finlay, JL; Gardner, SL; Knopp, EA; Levy, AS; Miller, DC; Weiner, HL; Wisoff, JH	1
Hausmaninger, H; Heilmann, V; Huebner, G; Nitsch, T; Possinger, K; Schippinger, W; Schmid, P; Schultze, W; Wischnewsky, M	1
Bachelez, H; Brice, P; Dubertret, L; Dupuy, A; Janin, A; Lebbé, C; Mebazaa, A; Morel, P; Moulonguet, I; Mouly, F; Rivet, J; Rybojad, M; Vignon-Pennamen, MD	1
Kobayashi, S	1
Baur, M; Dittrich, Ch; Gneist, M; Hudec, M; Schernhammer, E; Sevelda, P; Speiser, P	1
Albain, KS; Chansky, K; Crowley, JJ; Gandara, DR; Gaspar, LE; Livingston, RB; Rusch, V; Vallieres, E	1
Hakamada, A; Isoda, K; Mizutani, H; Nomura, E; Yamaguchi, M; Yamanaka, K	1
Ansari, RH; Ellerton, J; Green, MR; Herndon, JE; Kelly, K; Marks, RS; Miller, AA; Niell, HB; Otterson, G; Perry, MC; Sandler, AB; Vokes, EE; Watson, DM	1
Abrams, RA; Berkey, BA; Byhardt, RW; Curran, WJ; Duncan, PJ; Ettinger, DS; Fontanesi, J; Machtay, M; Movsas, B	1
Besse, B; Le Chevalier, T; Soria, JC	1
Bernstein, M; Blaney, S; Chen, Z; Fisher, PG; Freeman, C; Friedman, H; Greenberg, ML; Hershon, L; Korones, DN; Kretschmar, C; Zhou, T	1
Dolezal, J; Dolezel, M; Moravek, P; Odrazka, K; Petera, J; Prosvic, P; Simakova, E; Vaculikova, M; Vosmik, M; Zoul, Z	1
Glasmacher, A; Gorschlüter, M; Mey, U; Schmidt-Wolf, IG; Schwerdtfeger, R	1
Collette, L; de Mulder, PH; de Prijck, L; de Wit, R; Fosså, SD; Horwich, A; Kaiser, G; Koriakine, O; Paluchowska, B; van Oosterom, AT	1
Anderson, MA; Bowman, M; Deb, S; Deb, SP; Hassan, S; Miles, MF; Scian, MJ; Stagliano, KE	1
Clawson, S; Cullen, MH; Hancock, BW; Jack, AS; Johnson, PW; MacLennan, KA; Radford, JA; Ryder, D; Smith, P; Stenning, SP; Sydes, MR; Walewski, J	1
Managadze, L; Mezvrishvili, Z	1
Crump, M; Keating, A; Kuruvilla, J; Nagy, T; Pintilie, M; Tsang, R	1
Burton, C; Cunningham, D; Dyer, MJ; Hancock, B; Hoskin, P; Jack, A; Linch, D; MacLennan, K; Milligan, D; Mouncey, P; Qian, W; Smith, P; Webb, A	1
Antoneli, CB; Arias, VE; Chojniak, MM; Novaes, PE; Ribeiro, Kde C; Sakamoto, LH	1
Bisogno, G; Casale, F; Cecchetto, G; De Salvo, G; Di Martino, M; Di Tullio, MT; Donfrancesco, A; Donofrio, V; Ferrari, A; Indolfi, P; Martone, A	1
Bernbeck, B; Dilloo, D; Huck, K; Laws, HJ; Meisel, R; Pape, H; Schonberger, S; Stackelberg, VA; Traeger, A	1
Driver, D; Kilby, AM; McTiernan, A; Michelagnoli, MP; Whelan, JS	1
Dabbas, B; Ford, CD; Gabor, F; Morgan, R	1
De Braud, F; Di Meglio, G; Fazio, N; Grana, C; Lorizzo, K; Pelosi, G; Torrisi, R; Tradati, N	1
Callefe, LG; Ferman, S; Figueiredo, BC; Lichtvan, LL; Oliveira, BH; Parise, GA; Pianovski, MA; Piovezan, GC; Santana, MH; Stinghen, ST; Voss, SZ; Zancanella, P	1
Bernstein, M; Chen, Z; Donaldson, SS; Fryer, CJ; Gebhardt, MC; Grier, HE; Krailo, M; Laurie, F; Miser, JS; Tarbell, NJ; Yock, TI	1
Huh, J; Jeong, YP; Kim, S; Kim, SB; Kim, SW; Ko, OB; Koo, JE; Lee, D; Lee, JL; Park, SH; Suh, C	1
Classen, CF; Papke, K; Trotter, A; Wagner, S; Warmuth-Metz, M; Wolff, JE	1
Alloisio, M; Banna, GL; Castagna, L; De Giorgi, U; Ferrari, B; Marangolo, M; Rosti, G; Santoro, A	1
Bacik, J; Bajorin, DF; Bosl, GJ; Einhorn, L; Lara, PN; Margolin, KA; Mazumdar, M; Motzer, RJ; Nichols, CJ; Richardson, PG; Vogelzang, NJ	1
Arceci, RJ; Chen, AR; Colombani, P; Higman, MA; Schwartz, CL; Wharam, M; Williams, KM	1
Dahrouge, S; Jeyabalan, N; Laurie, SA; MacRae, R; Nicholas, G	1
Buchholz, E; Drings, P; Manegold, C; Pilz, L; Thatcher, N	1
Gergely, L; Illés, A; Keresztes, K; Miltényi, Z; Ress, Z; Simon, Z; Vadász, G; Váróczy, L	1
Chang, CC; Gondo, G; Hayashi, A; Ito, S; Kanno, H; Kyuma, Y; Nishimura, S; Ono, A; Sasaki, T; Sato, H; Shimizu, N; Tanaka, M; Yamamoto, I	1
Fujishima, M; Fujishima, N; Hirokawa, M; Inomata, M; Kameoka, Y; Saitoh, H; Saitoh, K; Sawada, K; Takahashi, N; Yamanaka, Y; Yoshioka, T	1
Abidi, MH; Ibrahim, RB; Maria, D; Peres, E; Tove, I	1
Cooney, KA; Dunn, RL; Fardig, JE; Mackler, NJ; Olson, KB; Pienta, KJ; Redman, BG; Smith, DC	1
Advani, R; Breslin, S; Hoppe, R; Horning, SJ; Lavori, P; Maeda, L; Quon, A; Rosenberg, SA	1
Briasoulis, E; Dimopoulos, MA; Economopoulos, T; Fountzilas, G; Kalofonos, HP; Kosmidis, P; Pectasides, D; Samantas, E; Skarlos, D; Syrigos, K	1
Goldman, S; Greenwald, MJ; Mets, MB; Reitman, AJ; Seshadri, R; Strauss, LC; Weinstein, JL; Zage, PE; Zeid, JL	1
Buchler, T; Ellis, P; Hackshaw, A; James, L; Lee, SM; Snee, M	1
Bauditz, J; Lochs, H; Ventz, M	1
Babić, DR; Jelić, SB; Jezdić, SD; Krivokapić, ZV; Micev, MT; Pesko, PM; Popov, IP	1
Bell, S; Doolittle, ND; Fortin, D; Jahnke, K; Knight, KR; Kraemer, DF; Muldoon, LL; Neuwelt, EA	1
Czyzewicz, G; Jasiówka, M; Kojs-Pasińska, E; Rolski, J; Zemełka, T	1
Caballero, D; Canals, C; Finke, J; Goldstone, A; Hunter, A; Kienast, J; Kobbe, G; Kolb, HJ; Kyriakou, C; Metzner, B; Oberg, G; Reimer, P; Schmitz, N; Sureda, A; Theorin, N	1
Ansell, S; Arndt, C; Buckner, J; Christianson, T; Galanis, E; Gill, P; Litzow, M; Moynihan, T	1
Alessandrino, EP; Arcaini, L; Bernasconi, P; Bonfichi, M; Bottelli, C; Brusamolino, E; Cairoli, R; Calatroni, S; Gargantini, L; Lazzarino, M; Majolino, I; Merli, M; Montanari, F; Morra, E; Pascutto, C; Passamonti, F; Rossi, G; Troletti, D; Tucci, A; Zoli, V	1
Arkenau, T; Cunningham, D; Horwich, A; Murphy, F; Norman, A; Oates, J; Powles, R; Sirohi, B; Wotherspoon, A	1
Barbui, T; Benedetti, F; Boccadoro, M; Ciceri, F; Corradini, P; Cortelazzo, S; Gallamini, A; Gianni, AM; Magni, M; Majolino, I; Mirto, S; Passera, R; Patti, C; Pileri, A; Pizzolo, G; Rambaldi, A; Tarella, C; Zanni, M	1
Dearnaley, DP; Hendry, WF; Horwich, A; Nicolls, J; Norman, A	1
Newton, CL; Newton, HB	1
Daly, PA; Goggins, MG; Kelleher, DP; McDonald, GS; O'Byrne, KJ; Weir, DG	1
Hirakawa, K; Horiike, S; Kaneko, H; Kashima, K; Misawa, S; Nakai, H; Nakao, M; Taniwaki, M; Ueda, Y	1
Ben-Arieh, Y; Ben-Shahar, M; Epelbaum, R; Freidin, N; Haim, N; Leviov, M; Reshef, R	1
Baldicchi, L; Corneo, GM; Mangiagalli, M; Miccolis, IR; Pioltelli, P; Pogliani, EM	1
Cera, PJ; Cha, SS; Creagan, ET; Goldberg, RM; Jung, SH; Marschke, RF; Myers, JL; Schleusener, JT; Tazelaar, HD	1
Cheong, SK; Kim, JS; Kim, YH; Lee, JD; Park, JS; Shin, SW	1
Atienza, DM; Swain, SM; Trock, B; Vogel, CL	1
Berman, M; Blessing, JA; Currie, JL; McGehee, R; Soper, JT	1
Bastit, D; Boulet, D; Fruchart, C; Moncondult, M; Piguet, H; Stamatoullas, A; Tilly, H	1
Bairey, O; Blickstein, D; Hadar, H; Lahav, M; Prokocimer, M; Shaklai, M; Shaklai, S; Sulkes, J	1
Bekradda, M; Culine, S; Droz, JP; Farhat, F; Terrier-Lacombe, MJ; Theodore, C	1
Byhardt, RW; Curran, WJ; Dundas, GS; Fossella, FV; Komaki, R; Lee, JS; McDonald, S; Scott, C	1
Bolzicco, G; Crinó, L; De Marinis, F; Emiliani, E; Figoli, F; Gentile, A; Marangolo, M; Maranzano, E; Masiero, P; Meacci, L; Morandi, MG; Ricardi, U; Rosti, G; Scagliotti, GV; Tonato, M	1
Chong, R; Goh, YT; Lee, LH; Ng, HS; Tan, P; Wong, GC	1
Burghouts, JT; Curran, D; Giaccone, G; Gozzelino, F; Groen, HJ; Kirkpatrick, A; Postmus, PE; Sahmoud, T; Scagliotti, G; Splinter, TA	1
Ameri, A; Delattre, JY; Monjour, A; Poisson, M; Ronchin, P; Sahmoud, T; Sanson, M	1
Golding, PF; Hamilton, CR; Kerr, J; Mead, GM; Milne, AE; O'Callaghan, A; Simmonds, PD; Smartt, P; Sweetenham, JW; Whitehouse, JM	1
Bezwoda, WR; Dansey, R; Davidge-Pitts, M	1
Collette, L; de Wit, R; Jones, WG; Kaye, SB; Rea, LA; Sleijfer, DT; Stoter, G; Sylvester, R; ten Bokkel Huinink, WW	1
Dardoufas, K; Dosios, T; Kosmas, C; Polyzos, A; Tsavaris, N; Veslemes, M	1
Chow, W; Doroshow, JH; Forman, SJ; Hamasaki, V; Lee, J; Leong, L; Margolin, K; Molina, A; Morgan, R; Odom-Maryon, T; Raschko, J; Shibata, S; Simpson, J; Somlo, G; Tetef, M; Yen, Y	1
Colleoni, M; Graiff, C; Manente, P; Nelli, P; Pancheri, F; Sgarbossa, G; Vicario, G	1
Aass, N; Cook, PA; Cullen, MH; Duchesne, GM; Fosså, SD; Harland, SJ; Horwich, A; Kaye, SB; Mead, GM; Oliver, RT; Read, G; Roberts, IT; Rustin, G; Stenning, SP	1
Andras, EJ; Asbell, SO; Byhardt, RW; Cox, JD; Emami, B; Komaki, R; Lee, JS; Rotman, M; Scott, C; Urtasun, RC	1
Pienta, KJ; Smith, DC	1
Allen, J; Bayer, L; Dunkel, IJ; Finlay, JL; Gardner, S; Garvin, J; Grovas, A; Halpern, S; Heller, G; Lindsley, K; Lyden, D; Mason, WP; Merchant, TE; O'Malley, B; Petriccione, MM; Puccetti, D; Rosenblum, M; Sands, S	1
Bodrogi, I; Collette, L; Cullen, M; De Prijck, L; deMulder, P; deWit, R; Fossa, S; Kaye, SB; Lallemand, E; Mead, GM; Stenning, S; Sylvester, R; van Groeningen, C	1
Bruera, E; Hewitt, J; Palmer, M; Rapp, E; Thaell, JF; Urtasun, R; Wood, L	1
Ahuja, RK; Bonner, JA; Creagan, ET; Johnson, PA; Mailliard, JA; Marschke, RF; McGinnis, WL; Shaw, EG; Sloan, JA; Stella, PJ	1
Keshelava, N; Reynolds, CP; Seeger, RC	1
Cheng, AL; Hung, RL; Liu, MY; Uen, WC; Wang, CH; Yeh, KH	1
Gulati, SC; Jhanwar-Uniyal, M	1
Benesch, M; Kerbl, R; Lackner, H; Oberbauer, R; Pakisch, B; Schwinger, W; Urban, C	1
Bergman, B; Helsing, M; Hero, U; Thaning, L	1
Groshen, S; Keshelava, N; Reynolds, CP; Seeger, RC	1
Bischoff, H; Diehl, V; Dühmke, E; Engert, A; Franklin, J; Georgii, A; Glunz, A; Haedicke, C; Hasenclever, D; Hermann, R; Holmer, L; Krause, S; Lathan, B; Loeffler, M; Paulus, U; Pfreundschuh, M; Rüffer, JU; Sextro, M; Sieber, M; Stappert-Jahn, U; Tesch, H; von Kalle, K; Winnerlein-Trump, E; Wolf, J; Wulf, G	1
Ambrosch, G; Huber, H; Mohn-Staudner, A; Oberaigner, W; Oroszy, S; Pfeifer, W; Pirker, R; Prior, C	1
Ashley, S; Atra, A; Kingston, JE; Mott, M; Pinkerton, CR; Shankar, AG	1
Curti, A; Lemoli, RM; Leopardi, G; Motta, MR; Rizzi, S; Testoni, N; Tura, S; Visani, G	1
Mollee, PN; Rodwell, R; Taylor, D; Taylor, KM; Williams, B	1
Fountzilas, G; Kalofonos, H; Kosmidis, P; Mylonakis, N; Nicolaides, P; Pavlidis, N; Pectasides, D; Samantas, E; Skarlos, DV; Vardoulakis, Th	1
Cavalli, F; Gueneau, M; Martinelli, G; Peccatori, F; Saletti, P; Zucca, E	1
Astoul, P; Boutin, C; Gouvernet, J; Irisson, M; Juin, P; Pignon, T; Ruggieri, S	1
Alberola, V; Antón, A; Artal, A; Barneto, I; Cardenal, F; Carrato, A; García, M; González-Larriba, JL; Lianes, P; Lomas, M; López-Cabrerizo, MP; Massuti, B; Montalar, J; Nguyen, B; Rosell, R; Vadell, C	1
Fushiki, H; Hasegawa, K; Izumi, R; Kono, I; Nishida, M; Noda, K; Noguchi, H; Okuda, H; Sugimori, H; Takizawa, K; Tanaka, T; Udagawa, Y; Umesaki, N; Yamamoto, K	1
Kosteljanetz, M; Kristjansen, PE; Lassen, U; Poulsen, HS; Wagner, A	1
Bonner, JA; Brooks, BJ; Gerstner, JB; Hillman, S; Jett, JR; Krook, JE; Levitt, R; Mailliard, JA; Maksymiuk, A; Marks, RS; Shanahan, TG; Sloan, JA; Tazelaar, HD	1
Bonadonna, G; Ferreri, AJ; Giardini, R; Rampinelli, I; Siracusano, L; Tondini, C; Valagussa, P	1
Andras, E; Byhardt, R; Cox, J; Dar, AR; Johnson, D; Komaki, R; Lawton, C; Lee, JS; Movsas, B; Roach, M; Sause, W; Scott, C; Wasserman, T	1
Bogart, JA; Chung, CT; Ryu, S; Ungureanu, C; Zamkoff, KW	1
Bonner, JA; Klee, GG; Krook, JE; Kugler, JW; Mailliard, JA; Maksymiuk, AW; Marks, RS; Perez, EA; Rowland, KM; Shaw, EG; Sloan, JA; Wiesenfeld, M	1
Haselow, RE; Kirkwood, JM; Leaf, AN; Wolf, BC	1
Caracciolo, D; Corradini, P; Cuttica, A; Gavarotti, P; Ladetto, M; Novero, D; Pileri, A; Rossi, G; Tarella, C; Zallio, F	1
Balcerzak, SP; Dana, BW; Fisher, RI; Forman, JD; Gaynor, ER; Kjeldsberg, C; LeBlanc, M; Miller, T; Roy, V; Unger, JM	1
Anderson, JR; Baker, KS; Breneman, JC; Crist, WM; Grier, HE; Link, MP; Maurer, HM; Qualman, SJ; Wiener, ES	1
Alvarnas, JC; Blume, KG; Chao, NJ; Horning, SJ; Hu, WW; Long, GD; Negrin, RS; Schriber, JR; Stockerl-Goldstein, K; Tierney, K; Wong, R	1
Aravantinos, G; Bafaloukos, D; Dimopoulos, MA; Kiamouris, C; Kosmidis, P; Papadimitriou, C; Papakostas, P; Pavlidis, N; Sikiotis, K; Skarlos, DV	1
Berglund, A; Carlson, K; Enblad, G; Glimelius, B; Hagberg, H	1
Balmer, A; Beck, MN; Dessing, C; Munier, F; Pica, A	1
Budel, L; Doorduijn, JK; Löwenberg, B; Sonneveld, P; Spruit, P; van Der Holt, B; van't Veer, M	1
Bonomi, PD; Kucuk, O; Pandya, KJ; Shevrin, DH	1
Jantunen, E; Mahlamäki, E; Nousiainen, T	1
Diehl, V; Engel, C; Loeffler, M; Schmitz, S; Tesch, H	1
Blume, KG; Hoppe, RT; Horning, SJ; Hu, WW; Johnston, LJ; Negrin, RS; Stockerl-Goldstein, KE	1
Bouafia, F; Coiffier, B; Dumontet, C; Espinouse, D; Hequet, O; Salles, G; Thieblemont, C	1
Guenther, PP; Huebner, A; Neumeister, V; Parwaresch, R; Sobottka, SB; Todt, H; Weissbach, G	1
Hsia, SH; Hsueh, C; Hung, IJ; Jaing, TH; Kao, CC; Tain, YL	1
Cervek, J; Cufer, T; Jagodic, M; Zakotnik, B	1
Bayer, R; Cairncross, G; Forsyth, P; Hu, W; Kaminer, L; Macdonald, D; Paleologos, N; Peterson, K; Ramsay, D; Rosenfeld, S; Salzman, D; Smith, A; Stewart, D; Swinnen, L	1
Baker, DL; Chan, KW; Davis, JH; Dickman, PS; Gerbing, RB; Gorlick, RG; Grovas, A; Herzog, CE; Krailo, MD; Ladanyi, M; Lindsley, KL; Liu-Mares, W; Meyers, PA; Nachman, JB; Sailer, SL; Sieger, L; Wadman, J	1
Munshi, HG; Pienta, KJ; Smith, DC	1
Ahmed, T; Feldman, EJ; Kancherla, R; Liu, D; Papageorgio, C; Pozzuoli, M; Seiter, K; Sreekantaiah, C; Weisberger, J; Weiss, M	1
Bando, T; Hasegawa, S; Hirata, T; Inui, K; Omasa, M; Shoji, T; Wada, H	1
Crooke, MJ; Delahunt, B; Lewis, ME; Pringle, KC; Wiltshire, EJ	1
Al-Mobarak, M; Badawood, S; Balawi, I; Meir, HM; Nayel, H; Yousef, MK	1
Briassoulis, E; Fountzilas, G; Kalofonos, HP; Kardamakis, D; Kosmidis, P; Kouvatseas, G; Panoussaki, E; Pavlidis, N; Samantas, E; Skarlos, DV; Tsavdaridis, D; Tsekeris, P; Tsiakopoulos, E; Tzitzikas, J; Zamboglou, N	1
Eriksson, B; Fjällskog, ML; Granberg, D; Grimfjärd, P; Oberg, K; Skogseid, B; Wilander, E	1
Angeles, S; Chak, P; Nimmagadda, N; Platt, AB; Wang, JC	1
Berger, F; Brice, P; Colin, P; Diviné, M; Fermé, C; Jaubert, J; Lederlin, P; Mounier, N; Reman, O; Salles, G; Stamatoullas, A; Voillat, L	1
Fukuda, N; Muraki, K; Ota, I; Shimohakamada, Y; Shinohara, K	1
Ansari, R; Einhorn, LH; Hanna, NH; Jung, SH; Lane, K; Loehrer, PJ; Sandier, AB	1
Hara, T; Hattori, H; Ishii, S; Matsuzaki, A; Suminoe, A	1
Boletis, J; Chiras, T; Kosmas, C; Kostakis, A; Tsavaris, NB; Vadiaka, M	1
Carde, P; Cavalli, F; Diehl, V; Franklin, J	1
Droz, JP; Flechon, A; Lombard-Bohas, C	1
Berg, S; Bernstein, M; Blaney, SM; Cherrick, I; Kuttesch, N; Murry, DJ; Salama, V	1
Broxson, EH; Dole, MG; Dunkel, IJ; Filippa, DA; George, D; Heath, JA; Lyden, D	1
Aebi, S; Betticher, DC; Calderoni, A; Solenthaler, M; von Briel, C	1
Gerrard, M; Hobson, R; Imeson, J; McCarthy, K; Pinkerton, CR; Williams, DM	1

Reviews

28 review(s) available for etoposide and Disease Exacerbation

Article	Year
Worsening of anti-Hu paraneoplastic neurological syndrome related to anti-PD-1 treatment: Case report and review of literature. Journal of neuroimmunology, 2020, 04-15, Volume: 341 Topics: Antibodies, Antinuclear; Antibodies, Neoplasm; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Autoantigens; Carboplatin; Carcinoma, Small Cell; Cerebellar Neoplasms; Combined Modality Therapy; Disease Progression; ELAV Proteins; Etoposide; Female; Humans; Lung Neoplasms; Middle Aged; Nivolumab; Paraneoplastic Syndromes, Nervous System; Programmed Cell Death 1 Receptor; Radiotherapy, Adjuvant; Treatment Outcome	2020
Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials. Cancer medicine, 2020, Volume: 9, Issue:18 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase III as Topic; Cyclophosphamide; Dacarbazine; Disease Progression; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasms, Second Primary; Prednisone; Procarbazine; Progression-Free Survival; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stem Cell Transplantation; Time Factors; Transplantation, Autologous; Vinblastine; Vincristine; Young Adult	2020
Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma. The Cochrane database of systematic reviews, 2017, 05-25, Volume: 5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease Progression; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Middle Aged; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Vinblastine; Vincristine; Young Adult	2017
Anticancer drug treatment for advanced lung cancer with interstitial lung disease. Respiratory investigation, 2018, Volume: 56, Issue:4 Topics: Albumins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Disease Progression; Etoposide; Follow-Up Studies; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Paclitaxel; Platinum; Retrospective Studies; Risk Assessment; Risk Factors	2018
Growing teratoma syndrome after ovarian inmature teratoma: a case report and review of the literature. Clinical and experimental obstetrics & gynecology, 2016, Volume: 43, Issue:6 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Cytoreduction Surgical Procedures; Disease Progression; Douglas' Pouch; Etoposide; Female; Humans; Hysterectomy; Lymph Nodes; Lymphatic Metastasis; Neoplasm Grading; Neoplasm, Residual; Omentum; Ovarian Neoplasms; Ovariectomy; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Reoperation; Salpingectomy; Syndrome; Teratoma; Tomography, X-Ray Computed; Ultrasonography	2016
Low-dose cisplatin-etoposide regimen for patients with optic pathway glioma: a report of four cases and literature review. Neuropediatrics, 2014, Volume: 45, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Disease Progression; Etoposide; Humans; Male; Optic Nerve Glioma	2014
[Hemophagocytic lymphohistiocytosis]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:2 Topics: Antibodies, Monoclonal, Murine-Derived; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cyclosporine; Disease Progression; Doxorubicin; Drug Therapy, Combination; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphohistiocytosis, Hemophagocytic; Methotrexate; Multiple Organ Failure; Prednisolone; Prednisone; Rituximab; Severity of Illness Index; Transplantation Conditioning; Vidarabine; Vincristine	2014
De novo large cell neuroendocrine carcinoma of the prostate gland with pelvic lymph node metastasis: a case report with review of literature. International journal of clinical and experimental pathology, 2014, Volume: 7, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Cystoscopy; Disease Progression; Etoposide; Fatal Outcome; Humans; Immunohistochemistry; Laparoscopy; Leuprolide; Lymph Node Excision; Lymphatic Metastasis; Male; Meningeal Neoplasms; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Paclitaxel; Pelvis; Prostatic Neoplasms; Robotic Surgical Procedures; Time Factors; Tomography, X-Ray Computed; Transurethral Resection of Prostate; Treatment Outcome	2014
High-dose chemotherapy as salvage treatment in germ-cell cancer: when, in whom and how. World journal of urology, 2017, Volume: 35, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Dose-Response Relationship, Drug; Etoposide; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Patient Selection; Salvage Therapy; Testicular Neoplasms; Vinblastine	2017
Contralateral testicular relapse after prophylactic radiation in a patient with primary testicular diffuse large B-cell lymphoma. European journal of haematology, 2009, Dec-01, Volume: 83, Issue:6 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Blood-Testis Barrier; Bone Marrow; Carboplatin; Central Nervous System Neoplasms; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Injections, Spinal; Lymphatic Metastasis; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Orchiectomy; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Salvage Therapy; Testicular Neoplasms; Transplantation Conditioning; Treatment Failure; Vincristine	2009
Purely intramedullary spinal cord primitive neuroectodermal tumor: case report and review of the literature. Neurocirugia (Asturias, Spain), 2009, Volume: 20, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Etoposide; Humans; Infant; Magnetic Resonance Imaging; Male; Methotrexate; Neuroectodermal Tumors, Primitive; Paraparesis; Prognosis; Spinal Cord Neoplasms; Thoracic Vertebrae	2009
The role of an all-oral chemotherapy containing lomustine (CCNU) in advanced,fs progressive Hodgkin lymphoma: a patient-friendly palliative option which can result in long-term disease control. Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:2 Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Disease Progression; Dose-Response Relationship, Drug; Etoposide; Hodgkin Disease; Humans; Lomustine; Palliative Care; Patient Satisfaction; Prednisolone; Survival Analysis; Survivors; Time Factors	2010
Radiotherapy in small-cell lung cancer: where should it go? Lung cancer (Amsterdam, Netherlands), 2010, Volume: 69, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Disease Progression; Early Detection of Cancer; Etoposide; Humans; Lung Neoplasms; Neoplasm Staging; Radiotherapy; Small Cell Lung Carcinoma	2010
Resistance to targeted therapies in pancreatic neuroendocrine tumors (PNETs): molecular basis, preclinical data, and counteracting strategies. Targeted oncology, 2012, Volume: 7, Issue:3 Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Drug Resistance, Neoplasm; Etoposide; Everolimus; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indoles; Medical Oncology; Neuroendocrine Tumors; Pancreatic Neoplasms; Pyrroles; Sirolimus; Sunitinib; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A	2012
Yolk sac tumor of the bilateral basal ganglia in a patient with Down syndrome. Brain tumor pathology, 2013, Volume: 30, Issue:4 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Basal Ganglia; Brain Neoplasms; Chemoradiotherapy; Cisplatin; Disease Progression; Down Syndrome; Endodermal Sinus Tumor; Etoposide; Female; Humans; Ifosfamide; Magnetic Resonance Imaging; Paresis; Treatment Outcome	2013
Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study. Neurology, 2004, Feb-10, Volume: 62, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Cranial Irradiation; Cytarabine; Dementia; Dementia, Vascular; Demyelinating Diseases; Disease Progression; Doxorubicin; Epilepsy, Complex Partial; Etoposide; Eye Neoplasms; Fatal Outcome; Female; Gait Disorders, Neurologic; Humans; Immunocompetence; Intracranial Arteriosclerosis; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Procarbazine; Radiation Injuries; Retrospective Studies; Survival Analysis; Thiotepa; Vincristine	2004
Analysis of treatment for small cell cancer of the bladder and report of three cases. Urology, 2004, Volume: 64, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Biomarkers, Tumor; Bone Neoplasms; Carboplatin; Carcinoma, Small Cell; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Deoxycytidine; Disease Progression; Etoposide; Gemcitabine; Humans; Life Tables; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasms, Second Primary; Prostatectomy; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms; Urinary Diversion	2004
Outcome of elderly patients with aggressive Non-Hodgkin's lymphoma refractory to or relapsing after first-line CHOP or CHOP-like chemotherapy: a low probability of cure. Leukemia & lymphoma, 2004, Volume: 45, Issue:7 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Drug Evaluation; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Life Tables; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome; Vincristine	2004
Recurrent ovarian cancer: how important is it to treat to disease progression? Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Nov-15, Volume: 10, Issue:22 Topics: Altretamine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Deoxycytidine; Disease Progression; Docetaxel; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; Ovarian Neoplasms; Paclitaxel; Recurrence; Risk; Taxoids; Time Factors; Topotecan	2004
Trilateral retinoblastoma. Pediatric blood & cancer, 2007, Volume: 48, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease Progression; Etoposide; Eye Enucleation; Eye Neoplasms; Fatal Outcome; Female; Humans; Idarubicin; Ifosfamide; Male; Methotrexate; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Neoplastic Syndromes, Hereditary; Pinealoma; Prognosis; Retinoblastoma; Vincristine	2007
Phase II study of oral etoposide for patients with advanced breast cancer. Cancer, 1995, Dec-15, Volume: 76, Issue:12 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Disease Progression; Etoposide; Female; Humans; Middle Aged; Treatment Outcome	1995
BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group. Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9 Suppl 5 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease Progression; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Survival Rate; Treatment Outcome; Vinblastine; Vincristine	1998
Secondary acute myelogenous leukemia and myelodysplasia without abnormalities of chromosome 11q23 following treatment of acute leukemia with topoisomerase II-based chemotherapy. Leukemia, 2001, Volume: 15, Issue:6 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human, Pair 11; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cytarabine; Disease Progression; Disease-Free Survival; Enzyme Inhibitors; Etoposide; Female; Humans; Idarubicin; Incidence; Karyotyping; Leukemia, Myeloid; Life Tables; Male; Middle Aged; Mitoxantrone; Myelodysplastic Syndromes; Neoplasm Proteins; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies; Topoisomerase II Inhibitors; Treatment Outcome; Tretinoin	2001
Therapy-related myelodysplastic syndrome in a case of cutaneous adult T-cell lymphoma. International journal of hematology, 2002, Volume: 75, Issue:1 Topics: Acute Disease; Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosome Aberrations; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Fatal Outcome; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Japan; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid; Lymphoma, T-Cell, Cutaneous; Male; Nitrosourea Compounds; Prednisolone; Proviruses; Radiotherapy; Remission Induction; Translocation, Genetic; Vincristine	2002
Unrelated cord blood transplantation for an infant with chemotherapy-resistant progressive Langerhans cell histiocytosis. Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:9 Topics: Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Etoposide; Fetal Blood; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histiocytosis, Langerhans-Cell; Humans; Infant; Male; Mercaptopurine; Methotrexate; Methylprednisolone; Mitoxantrone; Prednisolone; Remission Induction; Transplantation Conditioning; Transplantation, Homologous; Vincristine	2001
Is escalated BEACOPP a standard therapy for advanced Hodgkin's disease? The hematology journal : the official journal of the European Haematology Association, 2000, Volume: 1, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Clinical Trials, Phase III as Topic; Cyclophosphamide; Dacarbazine; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Hodgkin Disease; Humans; Infertility; Mechlorethamine; Prednisolone; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies; Safety; Treatment Outcome; Vinblastine; Vincristine	2000
[Chemotherapy of neuroendocrine tumors]. La Revue du praticien, 2002, Feb-01, Volume: 52, Issue:3 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Doxorubicin; Embolization, Therapeutic; Etoposide; Humans; Neuroendocrine Tumors; Prognosis; Streptozocin; Survival Analysis	2002
Anaplastic large cell lymphoma in childhood: analysis of 72 patients treated on The United Kingdom Children's Cancer Study Group chemotherapy regimens. British journal of haematology, 2002, Volume: 117, Issue:4 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Infant; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Prednisolone; Recurrence; Risk; Thioguanine; United Kingdom; Vincristine	2002

Trials

126 trial(s) available for etoposide and Disease Exacerbation

Article	Year
Phase II study of IRInotecan treatment after COmbined chemo-immunotherapy for extensive-stage small cell lung cancer: Protocol of IRICO study. Thoracic cancer, 2023, Volume: 14, Issue:28 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Clinical Trials, Phase II as Topic; Disease Progression; Etoposide; Humans; Immunotherapy; Irinotecan; Lung Neoplasms; Neoplasm Recurrence, Local; Platinum; Small Cell Lung Carcinoma	2023
Early Progression and Immune Reconstitution Inflammatory Syndrome During Treatment of Mild-To-Moderate Kaposi Sarcoma in Sub-Saharan Africa and South America: Incidence, Long-Term Outcomes, and Effects of Early Chemotherapy. Journal of acquired immune deficiency syndromes (1999), 2020, 08-01, Volume: 84, Issue:4 Topics: Adult; Africa South of the Sahara; Anti-HIV Agents; Antineoplastic Agents, Phytogenic; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Disease Progression; Etoposide; Female; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Male; Sarcoma, Kaposi; South America; Treatment Outcome	2020
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021, 02-20, Volume: 39, Issue:6 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Carboplatin; Disease Progression; Double-Blind Method; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Small Cell Lung Carcinoma; Survival Analysis	2021
Metronomic Chemotherapy vs Best Supportive Care in Progressive Pediatric Solid Malignant Tumors: A Randomized Clinical Trial. JAMA oncology, 2017, Sep-01, Volume: 3, Issue:9 Topics: Administration, Metronomic; Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Celecoxib; Child; Child, Preschool; Cyclophosphamide; Disease Progression; Disease-Free Survival; Double-Blind Method; Etoposide; Female; Follow-Up Studies; Humans; Male; Neoplasms; Response Elements; Retreatment; Sarcoma, Ewing; Survival Rate; Thalidomide; Time Factors	2017
Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas. Leukemia & lymphoma, 2018, Volume: 59, Issue:6 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Humans; Kaplan-Meier Estimate; Lymphoma, T-Cell, Peripheral; Neoplasm Staging; Prednisone; Rituximab; Treatment Outcome; Vincristine	2018
Reduced-dose EPOCH-R chemotherapy for elderly patients with advanced stage diffuse large B cell lymphoma. Annals of hematology, 2018, Volume: 97, Issue:10 Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasm Staging; Prednisone; Prognosis; Rituximab; Treatment Outcome; Vincristine	2018
Apatinib combined with oral etoposide in patients with platinum-resistant or platinum-refractory ovarian cancer (AEROC): a phase 2, single-arm, prospective study. The Lancet. Oncology, 2018, Volume: 19, Issue:9 Topics: Administration, Oral; Adolescent; Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Platinum Compounds; Progression-Free Survival; Prospective Studies; Pyridines; Time Factors; Young Adult	2018
Association of Chemoradiotherapy With Outcomes Among Patients With Stage I to II vs Stage III Small Cell Lung Cancer: Secondary Analysis of a Randomized Clinical Trial. JAMA oncology, 2019, 03-01, Volume: 5, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Disease Progression; Dose Fractionation, Radiation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Progression-Free Survival; Prospective Studies; Radiotherapy, Conformal; Small Cell Lung Carcinoma; Time Factors	2019
Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial. Bone marrow transplantation, 2014, Volume: 49, Issue:3 Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carboplatin; Disease Progression; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Prospective Studies; Recurrence; Risk Factors; Rituximab; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Young Adult	2014
A randomised phase 2 trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor-prognosis germ cell tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604). European urology, 2015, Volume: 67, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Disease Progression; Disease-Free Survival; Etoposide; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Proportional Hazards Models; Testicular Neoplasms; Time Factors; Treatment Outcome; United Kingdom; Vincristine; Young Adult	2015
Phase 2 study of accelerated hypofractionated thoracic radiation therapy and concurrent chemotherapy in patients with limited-stage small-cell lung cancer. International journal of radiation oncology, biology, physics, 2015, Mar-01, Volume: 91, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Disease-Free Survival; Dose Fractionation, Radiation; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Small Cell Lung Carcinoma	2015
A multicenter, open-label, randomized phase II controlled study of rh-endostatin (Endostar) in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2015, Volume: 10, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease Progression; Disease-Free Survival; Endostatins; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Small Cell Lung Carcinoma; Young Adult	2015
Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial†. Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:5 Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cisplatin; Cyclophosphamide; Disease Progression; Disease-Free Survival; Epirubicin; Etoposide; Female; France; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Proportional Hazards Models; Risk Factors; Small Cell Lung Carcinoma; Time Factors; Treatment Outcome; Young Adult	2015
Phase II study of interim PET-CT-guided response-adapted therapy in advanced Hodgkin's lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:6 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; India; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Procarbazine; Prospective Studies; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine; Young Adult	2015
Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, May-20, Volume: 33, Issue:15 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Disease Progression; Disease-Free Survival; Double-Blind Method; Etoposide; Female; Humans; Indoles; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Proportional Hazards Models; Pyrroles; Small Cell Lung Carcinoma; Sunitinib; Treatment Outcome	2015
Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study. British journal of haematology, 2015, Volume: 169, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Nitrosourea Compounds; Prednisolone; Treatment Outcome; Vincristine; Vindesine	2015
Efficacy of oral Etoposide in pretreated metastatic breast cancer: a multicenter phase 2 study. Medicine, 2015, Volume: 94, Issue:17 Topics: Administration, Oral; Adult; Aged; Anthracyclines; Breast Neoplasms; China; Disease Progression; Etoposide; Female; Humans; Middle Aged; Salvage Therapy; Survival Rate; Taxoids; Treatment Outcome	2015
A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902. International journal of radiation oncology, biology, physics, 2015, Oct-01, Volume: 93, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Progression; Early Termination of Clinical Trials; Estramustine; Etoposide; Humans; Male; Middle Aged; Neoplasm Grading; Paclitaxel; Prostate-Specific Antigen; Prostatic Neoplasms; Time Factors	2015
Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, Jan-10, Volume: 34, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemoradiotherapy; Child; Child, Preschool; Cyclophosphamide; Disease Progression; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Irinotecan; Lymphatic Metastasis; Male; Middle Aged; Patient Selection; Radiotherapy, Adjuvant; Rhabdomyosarcoma; Risk Assessment; Risk Factors; Severity of Illness Index; Treatment Outcome; Vincristine	2016
Phase II trial of ofatumumab plus ESHAP (O-ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first-line chemotherapy. British journal of haematology, 2016, Volume: 174, Issue:6 Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cytarabine; Disease Progression; Drug Resistance, Neoplasm; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Recurrence; Retreatment; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Young Adult	2016
Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008). Oncotarget, 2016, Dec-20, Volume: 7, Issue:51 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemoradiotherapy; Cisplatin; Dexamethasone; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Radiotherapy Dosage; Radiotherapy, Conformal; Republic of Korea; Time Factors; Treatment Outcome	2016
A randomized, double-blind, phase 2 trial of platinum therapy plus etoposide with or without concurrent vandetanib (ZD6474) in patients with previously untreated extensive-stage small cell lung cancer: Hoosier Cancer Research Network LUN06-113. Cancer, 2017, 01-01, Volume: 123, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Disease Progression; Double-Blind Method; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Piperidines; Quinazolines; Small Cell Lung Carcinoma	2017
Retrospective study of efficacy and toxicity on patients older than 70 years within a randomized clinical trial of two cisplatin-based combinations in patients with small-cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2009, Volume: 63, Issue:1 Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Epirubicin; Etoposide; Humans; Lung Neoplasms; Middle Aged; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Treatment Outcome	2009
FDG-PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin's lymphoma has a high negative predictive value. Annals of oncology : official journal of the European Society for Medical Oncology, 2009, Volume: 20, Issue:7 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Procarbazine; Prognosis; Radiopharmaceuticals; Treatment Outcome; Vincristine; Young Adult	2009
Phase II study of celecoxib with cisplatin plus etoposide in extensive-stage small cell lung cancer. Cancer investigation, 2009, Volume: 27, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cisplatin; Cyclooxygenase 2 Inhibitors; Disease Progression; Etoposide; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Portugal; Pyrazoles; Quality of Life; Small Cell Lung Carcinoma; Spain; Sulfonamides; Time Factors; Treatment Outcome	2009
Phase II study of ifosfamide, carboplatin, and etoposide in patients with a first recurrence of glioblastoma multiforme. Journal of neurosurgery, 2010, Volume: 112, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Disease Progression; Etoposide; Female; Glioblastoma; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Quality of Life; Time Factors; Treatment Outcome; Young Adult	2010
Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis in locally advanced breast cancer patients: an update of the Southern Italy Cooperative Oncology Group (SICOG) randomised trial 9908. Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:4 Topics: Adult; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Cisplatin; Combined Modality Therapy; Disease Progression; Drug Administration Schedule; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Italy; Middle Aged; Paclitaxel; Preoperative Care; Taxoids	2010
Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma. Blood, 2010, Apr-15, Volume: 115, Issue:15 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; HIV; Humans; Infusions, Intravenous; Lymphoma, B-Cell; Male; Middle Aged; Prednisone; Rituximab; Treatment Outcome; Vincristine	2010
Phase III study comparing sequential versus alternate administration of cisplatin-etoposide and topotecan as first-line treatment in small cell lung cancer. Anticancer research, 2010, Volume: 30, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Patient Compliance; Small Cell Lung Carcinoma; Survival Rate; Topotecan	2010
Use of G-CSF during concurrent chemotherapy and thoracic radiotherapy in patients with limited-stage small-cell lung cancer safety data from a phase II trial. Lung cancer (Amsterdam, Netherlands), 2011, Volume: 74, Issue:1 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Disease Progression; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Platelet Transfusion; Small Cell Lung Carcinoma; Survival Analysis; Thrombocytopenia	2011
Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. Journal of the National Cancer Institute, 2011, Oct-05, Volume: 103, Issue:19 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Canada; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Confounding Factors, Epidemiologic; Disease Progression; Dose Fractionation, Radiation; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Odds Ratio; Radiotherapy Dosage; Radiotherapy, Adjuvant; Time Factors; Treatment Outcome; United States; Vinblastine	2011
Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Sep-01, Volume: 30, Issue:25 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Europe; Female; Humans; Kaplan-Meier Estimate; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Prednisone; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Stem Cell Transplantation; Time Factors; Transplantation, Autologous; Treatment Outcome; Vincristine; Young Adult	2012
The impact of preradiation residual disease volume on time to locoregional failure in cutaneous Merkel cell carcinoma--a TROG substudy. International journal of radiation oncology, biology, physics, 2013, May-01, Volume: 86, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Chemoradiotherapy; Disease Progression; Disease-Free Survival; Dose Fractionation, Radiation; Etoposide; Female; Humans; Lymph Nodes; Lymphatic Irradiation; Male; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Pilot Projects; Proportional Hazards Models; Prospective Studies; Skin Neoplasms; Time Factors; Treatment Failure	2013
Radiotherapy alone versus radiochemotherapy in patients with stage IIIA adenocarcinoma (ADC) of the lung. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2013, Volume: 15, Issue:9 Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Chemoradiotherapy; Disease Progression; Disease-Free Survival; Dose Fractionation, Radiation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Prospective Studies; Radiotherapy; Time Factors	2013
Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Jul-15, Volume: 20, Issue:14 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Small Cell; Cisplatin; Disease Progression; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Infusions, Intravenous; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Prostatic Neoplasms; Survival Analysis; Treatment Outcome	2002
Allogeneic stem-cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH (+/- fludarabine) conditioning combined with post-transplant donor-lymphocyte infusion. Cytotherapy, 2001, Volume: 3, Issue:3 Topics: Adolescent; Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Blood Donors; Carmustine; Cytarabine; Disease Progression; Etoposide; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppression Therapy; Lymphocyte Transfusion; Lymphoproliferative Disorders; Male; Melphalan; Middle Aged; Monitoring, Physiologic; Secondary Prevention; Stem Cell Transplantation; Survival Rate; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome	2001
Cisplatin-etoposide alternating with topotecan in patients with extensive stage small cell lung cancer (SCLC). A multicenter phase II study. Lung cancer (Amsterdam, Netherlands), 2002, Volume: 38, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Disease Progression; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Survival; Thrombocytopenia; Topotecan; Treatment Outcome	2002
Etoposide, leucovorin (LV) and 5-fluorouracil (5-FU) in 5-FU+LV pre-treated patients with advanced colorectal cancer. Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:4 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Disease Progression; Etoposide; Feasibility Studies; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Safety; Salvage Therapy; Survival Rate	2002
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. The New England journal of medicine, 2003, Feb-20, Volume: 348, Issue:8 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Neuroectodermal Tumors, Primitive; Prognosis; Sarcoma; Sarcoma, Ewing; Survival Rate; Treatment Failure; Vincristine	2003
Malignant retroperitoneal and abdominal germ cell tumors: an intergroup study. Journal of pediatric surgery, 2003, Volume: 38, Issue:3 Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Etoposide; Female; Germinoma; Humans; Infant; Life Tables; Male; Neoplasm Staging; Remission Induction; Retroperitoneal Neoplasms; Survival Analysis; Treatment Outcome	2003
14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, May-01, Volume: 21, Issue:9 Topics: Adolescent; Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Leukopenia; Male; Middle Aged; Prednisone; Procarbazine; Survival; Thrombocytopenia; Treatment Outcome; Vincristine	2003
Phase II trial of paclitaxel, estramustine, etoposide, and carboplatin in the treatment of patients with hormone-refractory prostate carcinoma. Cancer, 2003, Jul-15, Volume: 98, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease Progression; Estramustine; Etoposide; Humans; Male; Middle Aged; Paclitaxel; Prostate-Specific Antigen; Prostatic Neoplasms; Rats; Survival Rate; Treatment Outcome	2003
The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Sep-01, Volume: 21, Issue:17 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chi-Square Distribution; Cisplatin; Combined Modality Therapy; Disease Progression; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Radiotherapy Dosage; Retrospective Studies; Survival Analysis; Treatment Outcome	2003
Randomized phase III trial of paclitaxel, etoposide, and carboplatin versus carboplatin, etoposide, and vincristine in patients with small-cell lung cancer. Journal of the National Cancer Institute, 2003, Aug-06, Volume: 95, Issue:15 Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Patient Selection; Prognosis; Proportional Hazards Models; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine	2003
Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Sep-15, Volume: 21, Issue:18 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Prospective Studies; Recurrence; Remission Induction; Sarcoma, Ewing; Vincristine	2003
A phase II trial of concurrent chemoradiation therapy followed by consolidation chemotherapy with oral etoposide and cisplatin for locally advanced inoperable non-small cell lung cancers. Lung cancer (Amsterdam, Netherlands), 2003, Volume: 42, Issue:2 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Disease Progression; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Radiation Pneumonitis; Survival Analysis; Thrombocytopenia; Treatment Outcome	2003
A pilot study of CODOX-M/IVAC in primary refractory or relapsed high-grade non-Hodgkin's lymphoma. A Scotland and Newcastle Lymphoma Group Study. Haematologica, 2003, Volume: 88, Issue:12 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Injections, Spinal; Lenograstim; Leucovorin; Lymphoma, Non-Hodgkin; Male; Mesna; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pilot Projects; Prognosis; Recombinant Proteins; Salvage Therapy; Sepsis; Treatment Outcome; Vincristine	2003
Oral etoposide for recurrent/progressive sarcomas of childhood. Pediatric blood & cancer, 2004, Volume: 42, Issue:4 Topics: Administration, Oral; Adolescent; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Disease Progression; Etoposide; Female; Humans; Male; Neoplasms, Second Primary; Palliative Care; Recurrence; Remission Induction; Sarcoma; Survival Rate; Treatment Outcome	2004
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL. Blood, 2004, Aug-01, Volume: 104, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Doxorubicin; Drug Administration Schedule; Etoposide; Factor Analysis, Statistical; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; L-Lactate Dehydrogenase; Lymphoma, B-Cell; Lymphoma, T-Cell; Middle Aged; Prednisone; Prognosis; Recombinant Proteins; Survival Rate; Time Factors; Treatment Outcome; Vincristine	2004
ICE (ifosfamide, carboplatin, etoposide) as second-line chemotherapy in relapsed or primary progressive aggressive lymphoma--the Nordic Lymphoma Group experience. European journal of haematology, 2004, Volume: 73, Issue:3 Topics: Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease Progression; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Leukapheresis; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Peripheral Blood Stem Cell Transplantation; Recurrence; Scandinavian and Nordic Countries; Treatment Outcome	2004
Results of autologous transplantation in lymphoma are not improved by increasing the dose of etoposide in the BEAM regimen: a single-centre sequential-cohort study. Bone marrow transplantation, 2004, Volume: 34, Issue:8 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cohort Studies; Cytarabine; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Male; Melphalan; Middle Aged; Multivariate Analysis; Retrospective Studies; Time Factors; Transplantation Conditioning; Transplantation, Autologous	2004
Outcome of children with B cell lymphoma in Venezuela with the LMB-89 protocol. Pediatric blood & cancer, 2004, Volume: 43, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hepatitis B; Hepatitis B Vaccines; Humans; Hydrocortisone; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Recurrence; Treatment Outcome; Venezuela; Vincristine	2004
Sequential intraperitoneal topotecan and oral etoposide chemotherapy in recurrent platinum-resistant ovarian carcinoma: results of a phase II trial. Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Sep-15, Volume: 10, Issue:18 Pt 1 Topics: Administration, Oral; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carcinoma; Chromatography, High Pressure Liquid; Disease Progression; DNA; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Recurrence; Time Factors; Topotecan; Treatment Outcome	2004
Sequential chemotherapy regimens followed by high-dose therapy with stem cell transplantation in mantle cell lymphoma: an update of a prospective study. Haematologica, 2004, Volume: 89, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Life Tables; Lymphoma, Mantle-Cell; Peripheral Blood Stem Cell Transplantation; Prednisone; Prognosis; Prospective Studies; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Vincristine; Whole-Body Irradiation	2004
Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study. Gynecologic oncology, 2004, Volume: 95, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Disease Progression; Etoposide; Female; Germinoma; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Prospective Studies	2004
Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Dec-15, Volume: 22, Issue:24 Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Leucovorin; Male; Medulloblastoma; Mesna; Methotrexate; Risk Factors; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Vincristine	2004
Up-front tandem high-dose chemotherapy compared with standard chemotherapy with doxorubicin and paclitaxel in metastatic breast cancer: results of a randomized trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jan-20, Volume: 23, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease Progression; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Infusions, Intravenous; Middle Aged; Mitoxantrone; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Quality of Life; Survival Analysis; Treatment Outcome	2005
Phase I/II study of oral etoposide plus GM-CSF as second-line chemotherapy in platinum-pretreated patients with advanced ovarian cancer. British journal of cancer, 2005, Mar-28, Volume: 92, Issue:6 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms	2005
Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B Trial 9732. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jun-01, Volume: 23, Issue:16 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Disease Progression; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Prospective Studies; Recombinant Proteins; Survival Rate; Time Factors	2005
Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Aug-01, Volume: 23, Issue:22 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Disease Progression; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Survival Analysis	2005
Etoposide, vincristine, and cyclosporin A with standard-dose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: a pediatric oncology group phase I study. Pediatric blood & cancer, 2005, Oct-15, Volume: 45, Issue:5 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Disease Progression; Dose Fractionation, Radiation; Etoposide; Glioma; Humans; Radiotherapy Dosage; Vincristine	2005
Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948). British journal of cancer, 2005, Nov-28, Volume: 93, Issue:11 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Disease Progression; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Prognosis; Risk Assessment; Survival Analysis; Testicular Neoplasms; Treatment Outcome; Vincristine	2005
Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin's lymphoma: results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-20, Volume: 23, Issue:36 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Combined Modality Therapy; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisolone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine	2005
A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma. British journal of cancer, 2006, Mar-27, Volume: 94, Issue:6 Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Survival Analysis; Treatment Outcome; Vincristine	2006
Mitotane associated with cisplatin, etoposide, and doxorubicin in advanced childhood adrenocortical carcinoma: mitotane monitoring and tumor regression. Journal of pediatric hematology/oncology, 2006, Volume: 28, Issue:8 Topics: Administration, Oral; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Disease Progression; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Etoposide; Female; Follow-Up Studies; Humans; Male; Mitotane; Neoplasm Staging; Prospective Studies; Remission Induction; Survival Rate; Time Factors; Treatment Outcome	2006
Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Aug-20, Volume: 24, Issue:24 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Confounding Factors, Epidemiologic; Cyclophosphamide; Dactinomycin; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Pelvic Bones; Radiotherapy, Adjuvant; Sarcoma, Ewing; Treatment Outcome; Vincristine	2006
ESHAP salvage therapy for refractory and relapsed non-Hodgkin's lymphoma: a single center experience. The Korean journal of internal medicine, 2006, Volume: 21, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Disease Progression; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Salvage Therapy; Survival Analysis; Treatment Failure	2006
Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor? Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2006, Volume: 12, Issue:10 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Disease-Free Survival; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Humans; Ifosfamide; Kaplan-Meier Estimate; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Prospective Studies; Remission Induction; Salvage Therapy; Transplantation, Autologous; Treatment Outcome	2006
Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Jan-20, Volume: 25, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carboplatin; Cisplatin; Disease Progression; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Prognosis; Survival Analysis; Treatment Outcome	2007
Standard versus dose-intensified chemotherapy with sequential reinfusion of hematopoietic progenitor cells in small cell lung cancer patients with favorable prognosis. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2007, Volume: 2, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Disease Progression; Erythrocyte Transfusion; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Platelet Transfusion; Prognosis; Recombinant Proteins; Survival Rate	2007
Phase II evaluation of oral estramustine, oral etoposide, and intravenous paclitaxel in patients with hormone-sensitive prostate adenocarcinoma. Clinical genitourinary cancer, 2007, Volume: 5, Issue:5 Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Disease Progression; Estramustine; Etoposide; Feasibility Studies; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasms, Hormone-Dependent; Paclitaxel; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate; Treatment Outcome	2007
Combination chemotherapy with cisplatin, etoposide and irinotecan in patients with extensive small-cell lung cancer: A phase II study of the Hellenic Co-operative Oncology Group. Lung cancer (Amsterdam, Netherlands), 2007, Volume: 58, Issue:3 Topics: Adult; Aged; Camptothecin; Carcinoma, Small Cell; Cisplatin; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Etoposide; Female; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Survival Rate	2007
Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma. Pediatric blood & cancer, 2008, Volume: 50, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Blindness; Carboplatin; Child, Preschool; Combined Modality Therapy; Cryotherapy; Disease Progression; Etoposide; Eye Enucleation; Humans; Hyperthermia, Induced; Infant; Infant, Newborn; Laser Therapy; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Visual Acuity	2008
Phase II trial of thalidomide with chemotherapy and as maintenance therapy for patients with poor prognosis small-cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2008, Volume: 59, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Disease Progression; Etoposide; Female; Humans; Lung Neoplasms; Male; Prognosis; Survival Rate; Thalidomide; Treatment Outcome	2008
Bimonthly 24 h infusion of high-dose 5-fluorouracil vs EAP regimen in patients with advanced gastric cancer. A randomized phase II study. Medical oncology (Northwood, London, England), 2008, Volume: 25, Issue:1 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Male; Middle Aged; Prospective Studies; Stomach Neoplasms	2008
Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system. Cancer, 2008, Feb-01, Volume: 112, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Etoposide; Female; Humans; Infant; Infusions, Intra-Arterial; Male; Methotrexate; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Survival Analysis; Treatment Outcome	2008
Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:7 Topics: Adult; Anthracyclines; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Purging; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Genes, bcl-2; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Immunologic Factors; Immunosuppressive Agents; Kaplan-Meier Estimate; Lymphoma, Follicular; Male; Middle Aged; Multivariate Analysis; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Rituximab; Time Factors; Transplantation, Autologous; Treatment Outcome; Vincristine	2008
Accelerated chemotherapy for poor prognosis germ cell tumours. European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Disease Progression; Drug Administration Schedule; Etoposide; Follow-Up Studies; Germinoma; Humans; Male; Pilot Projects; Prognosis; Survival Rate; Testicular Neoplasms; Vincristine	1994
Attempted dose intensified cyclophosphamide, etoposide, and granulocyte colony-stimulating factor for treatment of malignant astrocytoma. Journal of neuro-oncology, 1995, Volume: 24, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cyclophosphamide; Disease Progression; Dose-Response Relationship, Drug; Etoposide; Evaluation Studies as Topic; Female; Granulocyte Colony-Stimulating Factor; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Survival Rate; Tomography, X-Ray Computed	1995
Intermediate and high-grade gastric non-Hodgkin's lymphoma: a prospective study of non-surgical treatment with primary chemotherapy, with or without radiotherapy. Leukemia & lymphoma, 1995, Volume: 17, Issue:3-4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Gastrointestinal Hemorrhage; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prospective Studies; Radiotherapy, Adjuvant; Stomach Neoplasms; Vincristine	1995
Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma. Cancer, 1996, Apr-01, Volume: 77, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Differentiation; Cisplatin; Disease Progression; Etoposide; Female; Humans; Hydrazines; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neuroendocrine Tumors; Prognosis; Staining and Labeling	1996
Phase II trial of Oral UFT and leucovorin in advanced gastric carcinoma. American journal of clinical oncology, 1996, Volume: 19, Issue:2 Topics: Administration, Oral; Adult; Aged; Antibiotics, Antineoplastic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Diarrhea; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Male; Middle Aged; Remission Induction; Stomach Neoplasms; Stomatitis; Survival Rate; Tegafur; Vomiting	1996
Phase II study of oral etoposide for patients with advanced breast cancer. Cancer, 1995, Dec-15, Volume: 76, Issue:12 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Disease Progression; Etoposide; Female; Humans; Middle Aged; Treatment Outcome	1995
Phase II trial of hydroxyurea, dacarbazine (DTIC), and etoposide (VP-16) in mixed mesodermal tumors of the uterus: a Gynecologic Oncology Group study. Gynecologic oncology, 1996, Volume: 61, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Disease Progression; Etoposide; Female; Humans; Hydroxyurea; Middle Aged; Mixed Tumor, Mesodermal; Neoplasm Recurrence, Local; Treatment Outcome; Uterine Neoplasms	1996
Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma. Cancer, 1996, Jun-01, Volume: 77, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Disease Progression; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Life Tables; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Recombinant Proteins; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome; Whole-Body Irradiation	1996
Severe myelotoxicity of oral etoposide in heavily pretreated patients with non-Hodgkin's lymphoma or chronic lymphatic leukemia. Cancer, 1996, Jun-01, Volume: 77, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Disease Progression; Disease Susceptibility; Etoposide; Female; Gastrointestinal Diseases; Humans; Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Remission Induction; Salvage Therapy	1996
Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:4 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Disease Progression; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Radiotherapy, Adjuvant; Survival Analysis; Treatment Failure; Treatment Outcome	1996
Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony-stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer. Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Disease Progression; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiotherapy, Adjuvant; Recombinant Proteins; Survival Rate	1996
Standard versus alternating non-cross-resistant chemotherapy in extensive small cell lung cancer: an EORTC Phase III trial. European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Carboplatin; Carcinoma, Small Cell; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Multivariate Analysis; Survival Analysis; Vincristine	1996
Treatment of recurrent malignant supratentorial gliomas with ifosfamide, carboplatin and etoposide: a phase II study. European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:13 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease Progression; Etoposide; Female; Glioblastoma; Glioma; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Supratentorial Neoplasms; Survival Rate; Tomography, X-Ray Computed	1996
PACE BOM chemotherapy: a 12-week regimen for advanced Hodgkin's disease. Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fertility; Follow-Up Studies; Hematologic Diseases; Hodgkin Disease; Humans; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisolone; Retreatment; Treatment Outcome; Vincristine	1997
Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Disease Progression; Etoposide; Germinoma; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Survival Analysis; Testicular Neoplasms	1997
Chemotherapy of non small cell lung cancer. A prospectively randomized study of cisplatin-etoposide versus cisplatin-mitomycin-vinblastine. Journal of chemotherapy (Florence, Italy), 1997, Volume: 9, Issue:2 Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Prospective Studies; Survival Rate; Vinblastine	1997
Phase II study of estramustine, oral etoposide, and vinorelbine in hormone-refractory prostate cancer. American journal of clinical oncology, 1997, Volume: 20, Issue:4 Topics: Administration, Oral; Aged; Aged, 80 and over; Anemia; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Disease Progression; Drug Administration Schedule; Estramustine; Etoposide; Humans; Male; Middle Aged; Neutropenia; Prostate-Specific Antigen; Prostatic Neoplasms; Remission Induction; Vinblastine; Vinorelbine	1997
Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06. American journal of clinical oncology, 1997, Volume: 20, Issue:5 Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Body Surface Area; Carcinoma, Non-Small-Cell Lung; Cause of Death; Cisplatin; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Disease Progression; Dose Fractionation, Radiation; Etoposide; Female; Humans; Injections, Intravenous; Karnofsky Performance Status; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Radiotherapy; Radiotherapy Dosage; Remission Induction; Sex Factors; Survival Rate; Treatment Outcome; Vinblastine; Weight Loss	1997
Paclitaxel, estramustine, and etoposide in the treatment of hormone-refractory prostate cancer. Seminars in oncology, 1997, Volume: 24, Issue:5 Suppl 15 Topics: Adenocarcinoma; Administration, Oral; Alopecia; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; DNA Replication; DNA, Neoplasm; Drug Administration Schedule; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Estramustine; Etoposide; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Microtubules; Nuclear Matrix; Paclitaxel; Prostate-Specific Antigen; Prostatic Neoplasms; Rats; Remission Induction; Tumor Cells, Cultured	1997
Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of Cancer Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Disease Progression; Etoposide; Germinoma; Humans; Ifosfamide; Male; Middle Aged; Prognosis; Survival Rate; Vincristine	1998
Results of a phase III, double-blind, placebo-controlled trial of megestrol acetate modulation of P-glycoprotein-mediated drug resistance in the first-line management of small-cell lung carcinoma. British journal of cancer, 1998, Volume: 77, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Disease-Free Survival; Double-Blind Method; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Lung Neoplasms; Male; Megestrol Acetate; Middle Aged; Neoplasm Proteins; Vincristine	1998
The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study. Cancer, 1998, Mar-15, Volume: 82, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Disease Progression; Dose Fractionation, Radiation; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy Dosage; Survival Analysis; Treatment Outcome	1998
Synchronous radiochemotherapy in unfavorable brain tumors of children and young adults. Journal of neuro-oncology, 1998, Volume: 39, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemical and Drug Induced Liver Injury; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Deafness; Disease Progression; Disease-Free Survival; Etoposide; Follow-Up Studies; Glioma; Hearing Loss; Hematologic Diseases; Humans; Ifosfamide; Infections; Life Tables; Lomustine; Medulloblastoma; Methotrexate; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Vincristine	1998
Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomised phase III trial. Joint Lung Cancer Study Group. European journal of cancer (Oxford, England : 1990), 1998, Volume: 34, Issue:7 Topics: Activities of Daily Living; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cognition; Disease Progression; Emotions; Etoposide; Female; Hematologic Diseases; Humans; Interpersonal Relations; Lung Neoplasms; Male; Middle Aged; Quality of Life; Survival Analysis; Treatment Outcome	1998
BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group. Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9 Suppl 5 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease Progression; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Survival Rate; Treatment Outcome; Vinblastine; Vincristine	1998
Advanced non-small-cell lung cancer: adjunctive interferon gamma in induction and maintenance therapy. Journal of cancer research and clinical oncology, 1999, Volume: 125, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Etoposide; Female; Humans; Interferon-gamma; Leukopenia; Lung Neoplasms; Male; Middle Aged; Survival Rate; Treatment Outcome; Vinblastine; Vinorelbine	1999
Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 1999, Volume: 23, Issue:2 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Disease Progression; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Risk Assessment; Survival Analysis	1999
Alternating chemotherapy and accelerated split-course irradiation in locally advanced nonsmall cell lung carcinoma. Cancer, 1999, May-15, Volume: 85, Issue:10 Topics: Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Disease Progression; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radiotherapy; Survival Analysis; Treatment Outcome; Vomiting, Anticipatory	1999
Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:1 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Disease Progression; Etoposide; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Quality of Life; Survival Rate	1999
Cervical adenocarcinoma, a novel combination chemotherapy with mitomycin C, etoposide, and cisplatin for advanced or recurrent disease. Gynecologic oncology, 1999, Volume: 75, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Etoposide; Female; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Uterine Cervical Neoplasms	1999
Treatment of newly diagnosed glioblastoma multiforme with carmustine, cisplatin and etoposide followed by radiotherapy. A phase II study. Journal of neuro-oncology, 1999, Volume: 43, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Disease Progression; Etoposide; Female; Glioblastoma; Humans; Male; Middle Aged; Radiotherapy; Survival Analysis	1999
Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Disease Progression; Dose Fractionation, Radiation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Radiation Injuries; Sensitivity and Specificity; Survival Analysis	1999
The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies. International journal of radiation oncology, biology, physics, 1999, Dec-01, Volume: 45, Issue:5 Topics: Adenocarcinoma; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease Progression; Etoposide; Humans; Karnofsky Performance Status; Lung Neoplasms; Middle Aged; Neoplasm Staging; Prospective Studies; Quality-Adjusted Life Years; Survival Analysis	1999
Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Megestrol; Middle Aged; Neoplasm Staging; Phosphopyruvate Hydratase; Survival Rate; Time Factors	2000
Phase II study of etoposide (VP-16) in patients with thyroid cancer with no prior chemotherapy: an Eastern Cooperative Oncology Group Study (E1385). Medical oncology (Northwood, London, England), 2000, Volume: 17, Issue:1 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Disease Progression; Etoposide; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Sample Size; Thyroid Hormones; Thyroid Neoplasms; Treatment Outcome	2000
Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: results of the Southwest Oncology Group randomized phase III study 8809. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Recombinant Proteins; Remission Induction; Vincristine	2000
Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease Progression; Disease-Free Survival; Etoposide; Female; Head and Neck Neoplasms; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Neoplasm Staging; Prognosis; Retrospective Studies; Rhabdomyosarcoma, Embryonal; Risk Factors; Vincristine	2000
Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistant paclitaxel-pretreated ovarian cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:5 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Middle Aged; Ovarian Neoplasms; Paclitaxel; Prognosis; Salvage Therapy; Survival Analysis	2000
First-line chemotherapy with local treatment can prevent external-beam irradiation and enucleation in low-stage intraocular retinoblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:15 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Disease Progression; Etoposide; Eye Enucleation; Female; Humans; Male; Retinal Neoplasms; Retinoblastoma; Treatment Outcome	2000
Etoposide, mitoxantrone and prednisone: a salvage regimen with low toxicity for refractory or relapsed non-Hodgkin's lymphoma. Haematologica, 2000, Volume: 85, Issue:8 Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow Diseases; Disease Progression; Disease-Free Survival; Etoposide; Female; Humans; L-Lactate Dehydrogenase; Life Tables; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neoplasm Proteins; Prednisone; Prognosis; Safety; Salvage Therapy; Survival Analysis; Treatment Outcome	2000
Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586). American journal of clinical oncology, 2000, Volume: 23, Issue:4 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cause of Death; Cisplatin; Diarrhea; Disease Progression; Etoposide; Female; Fluorouracil; Follow-Up Studies; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Remission Induction; Survival Rate	2000
Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group (GHSG). Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:9 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Platelets; Blood Transfusion; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Leukocyte Count; Leukocytes; Leukopenia; Male; Middle Aged; Platelet Count; Prednisone; Procarbazine; Survival Analysis; Thrombocytopenia; Time Factors; Treatment Outcome; Vincristine	2000
A prospective study of intensive induction therapy with high-dose consolidation in patients with aggressive non-Hodgkin's lymphoma and two or three adverse prognostic factors. Leukemia, 2000, Volume: 14, Issue:12 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Feasibility Studies; Female; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Prognosis; Prospective Studies; Treatment Outcome	2000
High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Jun-01, Volume: 19, Issue:11 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Disease Progression; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Melphalan; Neoplasm Metastasis; Prognosis; Sarcoma, Ewing; Transplantation, Autologous; Treatment Outcome; Whole-Body Irradiation	2001
Chemotherapy in patients with prostate specific antigen-only disease after primary therapy for prostate carcinoma: a phase II trial of oral estramustine and oral etoposide. Cancer, 2001, Jun-01, Volume: 91, Issue:11 Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Disease Progression; Disease-Free Survival; Estramustine; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatic Neoplasms; Treatment Outcome	2001
Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: a randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG). Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:9 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Disease Progression; Dose Fractionation, Radiation; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Survival Analysis; Thrombocytopenia; Treatment Outcome	2001
Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Jan-15, Volume: 20, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Male; Melphalan; Middle Aged; Mitoguazone; Recurrence; Salvage Therapy; Transplantation, Autologous; Vinblastine; Vinorelbine	2002
Maintenance daily oral etoposide versus no further therapy following induction chemotherapy with etoposide plus ifosfamide plus cisplatin in extensive small-cell lung cancer: a Hoosier Oncology Group randomized study. Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:1 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Disease Progression; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Survival Rate; Time Factors	2002
Intensive chemotherapy with whole blood stem-cell support and concurrent chest radiotherapy in small cell lung cancer: a phase I/II trial. Lung cancer (Amsterdam, Netherlands), 2002, Volume: 36, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chi-Square Distribution; Combined Modality Therapy; Disease Progression; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Prospective Studies; Radiotherapy Dosage; Survival Analysis; Treatment Outcome	2002

Other Studies

167 other study(ies) available for etoposide and Disease Exacerbation

Article	Year
Soluble guanylate cyclase signalling mediates etoposide resistance in progressing small cell lung cancer. Nature communications, 2021, 11-17, Volume: 12, Issue:1 Topics: Animals; Cyclic GMP-Dependent Protein Kinases; Disease Models, Animal; Disease Progression; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Neoplastic Cells, Circulating; Nitric Oxide; Nitric Oxide Synthase Type II; Receptors, Notch; Signal Transduction; Small Cell Lung Carcinoma; Soluble Guanylyl Cyclase	2021
Outcome and late effects of patients treated for childhood vaginal malignant germ cell tumors. Pediatric blood & cancer, 2023, Volume: 70, Issue:12 Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Disease Progression; Etoposide; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Treatment Outcome	2023
Linc00173 promotes chemoresistance and progression of small cell lung cancer by sponging miR-218 to regulate Etk expression. Oncogene, 2020, Volume: 39, Issue:2 Topics: Adult; Aged; beta Catenin; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cisplatin; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; Male; MicroRNAs; Middle Aged; Protein-Tyrosine Kinases; Repressor Proteins; RNA, Long Noncoding; Small Cell Lung Carcinoma	2020
Delayed Enucleation With Neoadjuvant Chemotherapy in Advanced Intraocular Unilateral Retinoblastoma: AHOPCA II, a Prospective, Multi-Institutional Protocol in Central America. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019, 11-01, Volume: 37, Issue:31 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central America; Chemotherapy, Adjuvant; Child; Child, Preschool; Disease Progression; Etoposide; Eye Enucleation; Female; Humans; Infant; Male; Neoadjuvant Therapy; Neoplasm Staging; Progression-Free Survival; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Risk Factors; Time Factors; Time-to-Treatment; Treatment Refusal; Vincristine	2019
Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019, 11-01, Volume: 37, Issue:31 Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Disease Progression; Etoposide; Eye Enucleation; Female; Humans; India; Infant; Infant, Newborn; Male; Neoplasm Recurrence, Local; Progression-Free Survival; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Risk Assessment; Risk Factors; Time Factors; United States; Vincristine	2019
Circulating tumor cell clusters and circulating tumor cell-derived explant models as a tool for treatment response. BioTechniques, 2020, Volume: 69, Issue:1 Topics: Animals; Antineoplastic Agents; Blood Cells; Disease Progression; Etoposide; Humans; Mice, Nude; Neoplastic Cells, Circulating; Platinum; Small Cell Lung Carcinoma	2020
Results of R-ESHAP as salvage therapy in refractory/relapsed follicular lymphoma: a real-world experience on behalf of GELCAB group. Annals of hematology, 2020, Volume: 99, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Disease Progression; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Lymphoma, Follicular; Male; Methylprednisolone; Middle Aged; Neoplasm Grading; Recurrence; Retrospective Studies; Rituximab; Salvage Therapy; Spain; Survival Analysis; Treatment Failure; Treatment Outcome; Young Adult	2020
Chemotherapy dosing and toxicity in a patient with muscular dystrophy. Cancer reports (Hoboken, N.J.), 2018, Volume: 1, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Disease Progression; Dose-Response Relationship, Drug; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Muscular Dystrophies, Limb-Girdle; Myelopoiesis; Palliative Care	2018
Histiocytic sarcoma progressing from follicular lymphoma and mimicking acquired hemophagocytic lymphohistiocytosis. Annals of hematology, 2020, Volume: 99, Issue:10 Topics: Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 18; Cyclophosphamide; Dexamethasone; Diagnosis, Differential; Disease Progression; Doxorubicin; Etoposide; Female; Histiocytic Sarcoma; Humans; Lymph Nodes; Lymphohistiocytosis, Hemophagocytic; Lymphoma, Follicular; Middle Aged; Prednisolone; Rituximab; Translocation, Genetic; Vincristine	2020
Efficacy and safety of oral metronomic etoposide in adult patients with metastatic osteosarcoma. Cancer medicine, 2021, Volume: 10, Issue:1 Topics: Administration, Metronomic; Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Disease Progression; Etoposide; Female; Humans; Male; Middle Aged; Osteosarcoma; Progression-Free Survival; Retrospective Studies; Time Factors; Young Adult	2021
The AI-discovered aetiology of COVID-19 and rationale of the irinotecan+ etoposide combination therapy for critically ill COVID-19 patients. Medical hypotheses, 2020, Volume: 144 Topics: Comorbidity; COVID-19; COVID-19 Drug Treatment; Critical Illness; Disease Outbreaks; Disease Progression; Drug Discovery; Drug Therapy, Combination; Etoposide; Humans; Irinotecan; SARS-CoV-2; Sepsis; Signal Transduction; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Treatment Outcome; Virus Internalization; Virus Replication	2020
HSATII RNA is induced via a noncanonical ATM-regulated DNA damage response pathway and promotes tumor cell proliferation and movement. Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-15, Volume: 117, Issue:50 Topics: Ataxia Telangiectasia Mutated Proteins; Bleomycin; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cytomegalovirus Infections; Disease Progression; DNA Damage; DNA Repair; DNA, Satellite; Etoposide; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Genetic Fitness; Humans; Repetitive Sequences, Nucleic Acid; RNA-Seq; RNA, Untranslated; Transcriptional Activation	2020
Focused Ultrasound-Mediated Blood-Brain Barrier Opening Increases Delivery and Efficacy of Etoposide for Glioblastoma Treatment. International journal of radiation oncology, biology, physics, 2021, 06-01, Volume: 110, Issue:2 Topics: Animals; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Chromatography, Liquid; Contrast Media; Disease Progression; Etoposide; Glioblastoma; Magnetic Resonance Imaging; Male; Mice; Microbubbles; Sonication; Tandem Mass Spectrometry; Ultrasonography, Interventional	2021
Chemotherapy in idiopathic pulmonary fibrosis and small-cell lung cancer with poor lung function. BMC pulmonary medicine, 2021, Apr-15, Volume: 21, Issue:1 Topics: Aged; Antineoplastic Agents; Disease Progression; Dyspnea; Etoposide; Female; Humans; Idiopathic Pulmonary Fibrosis; Lung; Lung Neoplasms; Male; Organoplatinum Compounds; Small Cell Lung Carcinoma; Tomography, X-Ray Computed; Treatment Outcome	2021
Escalated anthracycline dose in adult AML. The Lancet. Oncology, 2017, Volume: 18, Issue:5 Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cytarabine; Disease Progression; Disease-Free Survival; Etoposide; Humans; Idarubicin; Leukemia, Myeloid, Acute; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome	2017
TRP53 Mutants Drive Neuroendocrine Lung Cancer Through Loss-of-Function Mechanisms with Gain-of-Function Effects on Chemotherapy Response. Molecular cancer therapeutics, 2017, Volume: 16, Issue:12 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Models, Animal; Disease Progression; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neuroendocrine Tumors; Sirolimus; Small Cell Lung Carcinoma; Tumor Suppressor Protein p53	2017
Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3-mutation, localized transformation to EGFR-mutated SCLC, and acquired T790M EGFR-mutation. Lung cancer (Amsterdam, Netherlands), 2017, Volume: 113 Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Disease Progression; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Etoposide; Exons; Genetic Heterogeneity; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Receptor, Fibroblast Growth Factor, Type 3	2017
A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factor. British journal of haematology, 2018, Volume: 180, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Karyotype; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine	2018
An Outpatient, Dose-Intense, Intravenous Cisplatin and Oral Etoposide Regimen for the Treatment of Advanced, Platinum-Resistant Ovarian Cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2018, Volume: 28, Issue:3 Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Grading; Ovarian Neoplasms; Retrospective Studies	2018
[Non-Small Cell Lung Cancer - Development of Parallel Mechanisms of Resistance]. Pneumologie (Stuttgart, Germany), 2018, Volume: 72, Issue:7 Topics: Acrylamides; Aniline Compounds; Antineoplastic Agents; Carboplatin; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Disease Progression; Drug Resistance, Neoplasm; ErbB Receptors; Etoposide; Humans; Lung Neoplasms; Mutation; Piperazines; Protein Kinase Inhibitors; Treatment Outcome	2018
Early disease progression in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy. Cancer science, 2018, Volume: 109, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Cohort Studies; Dexamethasone; Disease Progression; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Multivariate Analysis; Prognosis; Survival Analysis; Young Adult	2018
Mutations in the P10 region of procaspase-8 lead to chemotherapy resistance in acute myeloid leukemia by impairing procaspase-8 dimerization. Cell death & disease, 2018, 05-01, Volume: 9, Issue:5 Topics: Aged; Antineoplastic Agents, Phytogenic; Base Sequence; bcl-2-Associated X Protein; BH3 Interacting Domain Death Agonist Protein; Biomarkers, Tumor; Caspase 8; Disease Progression; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Regulation, Leukemic; Genes, Reporter; Green Fluorescent Proteins; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Protein Multimerization; Proto-Oncogene Proteins c-bcl-2; Signal Transduction	2018
Growing teratoma syndrome in ovarian germ cell tumours - a diagnostic challenge, two case reports. JPMA. The Journal of the Pakistan Medical Association, 2018, Volume: 68, Issue:6 Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CA-125 Antigen; Cisplatin; Disease Progression; Etoposide; Female; Humans; Membrane Proteins; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Syndrome; Teratoma; Young Adult	2018
Safety and effective salvage regimen comprising a novel combination of brentuximab vedotin, L-asparaginase, and dexamethasone for refractory anaplastic large cell lymphoma, anaplastic lymphoma kinase negative. Hematological oncology, 2019, Volume: 37, Issue:2 Topics: Aged; Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brentuximab Vedotin; Carboplatin; Cyclophosphamide; Dexamethasone; Disease Progression; Doxorubicin; Etoposide; Humans; Ifosfamide; Immunoconjugates; Lymphoma, Large-Cell, Anaplastic; Male; Neoplasm Proteins; Prednisone; Remission Induction; Salvage Therapy; Tonsillar Neoplasms; Vincristine	2019
Lambert-Eaton myasthenic syndrome developing post-diagnosis of small-cell lung cancer. Internal medicine journal, 2018, Volume: 48, Issue:12 Topics: Aged; Antineoplastic Agents; Carboplatin; Diagnosis, Differential; Disease Progression; Etoposide; Humans; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Male; Neoplasm Staging; Neurologic Examination; Prognosis; Small Cell Lung Carcinoma; Terminal Care	2018
The clinical conundrum of managing relapsed small cell lung cancer. Cancer, 2019, 04-01, Volume: 125, Issue:7 Topics: Anthracyclines; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Benzodiazepinones; Carboplatin; Clinical Decision-Making; Disease Progression; Etoposide; Humans; Immunoconjugates; Irinotecan; Liver Neoplasms; Lung Neoplasms; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Nivolumab; Paclitaxel; Piperazines; Pyrimidines; Salvage Therapy; Small Cell Lung Carcinoma; Temozolomide; Thiourea; Topotecan	2019
A multicenter retrospective comparison of induction chemoimmunotherapy regimens on outcomes in transplant-eligible patients with previously untreated mantle cell lymphoma. Hematological oncology, 2019, Volume: 37, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease Progression; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy; Induction Chemotherapy; International Cooperation; Lymphoma, Mantle-Cell; Male; Melphalan; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Remission Induction; Retrospective Studies; Transplantation Conditioning; Treatment Outcome	2019
First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients. Annals of hematology, 2019, Volume: 98, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Staging; Prednisolone; Prednisone; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis; Transplantation, Autologous; Vincristine	2019
TGF-β1 protects colon tumor cells from apoptosis through XAF1 suppression. International journal of oncology, 2019, Volume: 54, Issue:6 Topics: Adaptor Proteins, Signal Transducing; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Disease Progression; Down-Regulation; Drug Resistance, Neoplasm; Etoposide; Fluorouracil; Gamma Rays; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Signaling System; Neoplasm Proteins; Promoter Regions, Genetic; ras Proteins; Transforming Growth Factor beta1	2019
High dose salvage therapy with dose intensive cyclophosphamide, etoposide and cisplatin may increase transplant rates for relapsed/refractory aggressive non-Hodgkin lymphoma. Leukemia & lymphoma, 2013, Volume: 54, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Recurrence; Salvage Therapy; Transplantation, Autologous; Treatment Outcome; Young Adult	2013
Relapse in medulloblastoma: what can be done after abandoning high-dose chemotherapy? A mono-institutional experience. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2013, Volume: 29, Issue:7 Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cranial Irradiation; Dacarbazine; Deoxycytidine; Disease Progression; Disease-Free Survival; Etoposide; Female; Gemcitabine; Humans; Irinotecan; Male; Medulloblastoma; Melphalan; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Patient Selection; Quality of Life; Radiotherapy; Retrospective Studies; Salvage Therapy; Temozolomide; Young Adult	2013
Chemoreduction improves eye retention in patients with retinoblastoma: a report from the German Retinoblastoma Reference Centre. The British journal of ophthalmology, 2013, Volume: 97, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Cyclophosphamide; Disease Progression; Etoposide; Eye Enucleation; Female; Humans; Infant; Male; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Vincristine; Visual Acuity	2013
Seven-year follow-up of allogeneic transplant using BCNU, etoposide, cytarabine and melphalan chemotherapy in patients with Hodgkin lymphoma after autograft failure: importance of minimal residual disease. Leukemia & lymphoma, 2014, Volume: 55, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease Progression; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Melphalan; Neoplasm Recurrence, Local; Neoplasm, Residual; Prognosis; Transplantation, Autologous; Transplantation, Homologous; Treatment Failure; Treatment Outcome	2014
[Exudative pericardial effusion and oligoarthritis in a patient newly diagnosed with myelodysplastic syndrome]. Medicina clinica, 2014, Jul-07, Volume: 143, Issue:1 Topics: Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Arthritis; Azacitidine; Cytarabine; Disease Progression; Etoposide; Fatal Outcome; Hepatomegaly; Humans; Idarubicin; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Middle Aged; Pericardial Effusion; Pleural Effusion; Serositis	2014
Langerhans cell sarcoma of the nasopharynx: a rare case. Scottish medical journal, 2013, Volume: 58, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cladribine; Cytarabine; Disease Progression; Etoposide; Fatal Outcome; Humans; Langerhans Cell Sarcoma; Male; Nasopharyngeal Neoplasms; Prednisone	2013
Eliminating encephalitogenic T cells without undermining protective immunity. Journal of immunology (Baltimore, Md. : 1950), 2014, Jan-01, Volume: 192, Issue:1 Topics: Animals; Apoptosis; B-Lymphocytes; CD4-Positive T-Lymphocytes; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Etoposide; Female; Immunologic Memory; Lymphocyte Activation; Lymphocyte Depletion; Lymphocytic choriomeningitis virus; Mice; Multiple Sclerosis; Recurrence; T-Lymphocytes	2014
Safety and efficacy of high-dose cyclophosphamide, etoposide and ranimustine regimen followed by autologous peripheral blood stem cell transplant for patients with diffuse large B-cell lymphoma. Leukemia & lymphoma, 2014, Volume: 55, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult	2014
In vitro chemosensitivity assay of ascites in epithelial ovarian cancer. European journal of gynaecological oncology, 2013, Volume: 34, Issue:6 Topics: Antineoplastic Agents; Ascites; Carboplatin; Carcinoma, Ovarian Epithelial; Coloring Agents; Deoxycytidine; Disease Progression; Drug Screening Assays, Antitumor; Epirubicin; Etoposide; Female; Fluorouracil; Gemcitabine; Humans; Kaplan-Meier Estimate; Ki-67 Antigen; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; Retrospective Studies; Survival Rate; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53	2013
Treatment of high-risk aggressive B-cell non-Hodgkin lymphomas with rituximab, intensive induction and high-dose consolidation: long-term analysis of the R-MegaCHOP-ESHAP-BEAM Trial. Leukemia & lymphoma, 2015, Volume: 56, Issue:1 Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Consolidation Chemotherapy; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Induction Chemotherapy; Lymphoma, B-Cell; Male; Melphalan; Methylprednisolone; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Podophyllotoxin; Prednisone; Prognosis; Rituximab; Treatment Outcome; Vincristine; Young Adult	2015
A population pharmacodynamic model for lactate dehydrogenase and neuron specific enolase to predict tumor progression in small cell lung cancer patients. The AAPS journal, 2014, Volume: 16, Issue:3 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Small Cell; Cisplatin; Disease Progression; Disease-Free Survival; Etoposide; Humans; L-Lactate Dehydrogenase; Lung Neoplasms; Models, Biological; Phosphopyruvate Hydratase; Population; Predictive Value of Tests	2014
Giant thoracoabdominal ganglioneuroblastoma in a 17-year-old patient. Asian cardiovascular & thoracic annals, 2014, Volume: 22, Issue:6 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Aorta, Thoracic; Carboplatin; Disease Progression; Etoposide; Fatal Outcome; Ganglioneuroblastoma; Humans; Kidney; Laparotomy; Male; Mediastinal Neoplasms; Neoplasm, Residual; Thoracotomy; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden	2014
[Successful treatment of metastatic testicular tumor of extreme size]. Magyar onkologia, 2014, Volume: 58, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Depression; Disease Progression; Drug Administration Schedule; Etoposide; Febrile Neutropenia; Humans; Interdisciplinary Communication; Male; Middle Aged; Orchiectomy; Patient Care Team; Prognosis; Quality of Life; Remission Induction; Status Epilepticus; Testicular Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Venous Thrombosis	2014
A case of an adult Langerhans cell sarcoma. International journal of dermatology, 2016, Volume: 55, Issue:1 Topics: Biopsy, Needle; Disease Progression; Drug Therapy, Combination; Etoposide; Fatal Outcome; Female; Humans; Immunohistochemistry; Langerhans Cell Sarcoma; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Nose; Positron-Emission Tomography; Prednisone; Rare Diseases; Risk Assessment; Skin Neoplasms; Vincristine	2016
High-dose chemotherapy with carmustine, etoposide, cytarabine and melphalan followed by autologous stem cell transplant is an effective treatment for elderly patients with poor-prognosis lymphoma. Leukemia & lymphoma, 2015, Volume: 56, Issue:8 Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease Progression; Etoposide; Female; France; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Prognosis; Recurrence; Retrospective Studies; Survival Analysis; Transplantation, Autologous; Treatment Outcome	2015
Chemotherapy intensification in patients with advanced seminoma and adverse prognostic factors. Journal of cancer research and clinical oncology, 2015, Volume: 141, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Disease Progression; Etoposide; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Prognosis; Salvage Therapy; Seminoma; Survival Analysis; Testicular Neoplasms	2015
Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis. Cancer discovery, 2015, Volume: 5, Issue:5 Topics: Animals; Binding Sites; Cell Line, Tumor; Cell Transformation, Neoplastic; Checkpoint Kinase 1; Conserved Sequence; Disease Progression; DNA Damage; DNA-Binding Proteins; Down-Regulation; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Genotype; Humans; Male; Mice; Mice, Knockout; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Binding; Protein Kinases; Proto-Oncogene Proteins c-ets; PTEN Phosphohydrolase; Trans-Activators; Transcription Factors; Transcription, Genetic; Transcriptional Regulator ERG; Tumor Suppressor Protein p53	2015
De novo pulmonary small cell carcinomas and large cell neuroendocrine carcinomas harboring EGFR mutations: Lack of response to EGFR inhibitors. Lung cancer (Amsterdam, Netherlands), 2015, Volume: 88, Issue:1 Topics: Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Neuroendocrine; Disease Progression; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Etoposide; Fatal Outcome; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Radiography; Small Cell Lung Carcinoma	2015
Extrapulmonary small cell carcinoma in head and neck. The Journal of laryngology and otology, 2015, Volume: 129 Suppl 2 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Disease Progression; Drug Combinations; Etoposide; Female; Head and Neck Neoplasms; Humans; Irinotecan; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Radiotherapy, Adjuvant; Survival Rate; Tegafur	2015
Malignant transformation of germinoma 14 years after onset: Favorable efficacy of oral etoposide. Pediatrics international : official journal of the Japan Pediatric Society, 2015, Volume: 57, Issue:3 Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Transformation, Neoplastic; Disease Progression; Dose-Response Relationship, Drug; Etoposide; Female; Forecasting; Germinoma; Humans; Magnetic Resonance Imaging; Pituitary Gland, Posterior; Time Factors; Young Adult	2015
Pei regimen: a therapeutic option in small cell lung cancer? A retrospective monoinstitutional analysis of 46 consecutive cases. Journal of translational medicine, 2015, Apr-24, Volume: 13 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Retrospective Studies; Small Cell Lung Carcinoma; Treatment Outcome	2015
A plant alkaloid, veratridine, potentiates cancer chemosensitivity by UBXN2A-dependent inhibition of an oncoprotein, mortalin-2. Oncotarget, 2015, Sep-15, Volume: 6, Issue:27 Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Colonic Neoplasms; Cytoplasm; Disease Progression; Enhancer Elements, Genetic; Etoposide; Female; Fluorouracil; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Green Fluorescent Proteins; HCT116 Cells; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Mice; Mice, Nude; Mitochondrial Proteins; Neoplasm Transplantation; Plant Extracts; Protein Array Analysis; Tumor Suppressor Protein p53; Ubiquitin; Ubiquitins; Veratridine	2015
Germ Cell Cancer and Multiple Relapses: Toxicity and Survival. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Oct-01, Volume: 33, Issue:28 Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cisplatin; Databases, Factual; Denmark; Disease Progression; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Proportional Hazards Models; Radiotherapy Dosage; Retreatment; Risk Factors; Testicular Neoplasms; Time Factors; Treatment Failure	2015
SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression. Molecular cell, 2015, Sep-17, Volume: 59, Issue:6 Topics: Amino Acid Sequence; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Movement; Cullin Proteins; Disease Progression; Etoposide; HEK293 Cells; Humans; Male; Molecular Sequence Data; Neoplasm Invasiveness; Nuclear Proteins; Prostatic Neoplasms; Protein Interaction Domains and Motifs; Proteolysis; Repressor Proteins; Trans-Activators; Transcriptional Regulator ERG; Tumor Suppressor Proteins; Ubiquitination	2015
Carboplatin and Etoposide in Heavily Pretreated Patients with Progressive High-Grade Glioma. Chemotherapy, 2014, Volume: 60, Issue:5-6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Disease Progression; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Retrospective Studies	2014
Hemophagocytic syndrome associated to a Hodgkin lymphoma. La Tunisie medicale, 2015, Volume: 93, Issue:6 Topics: Antineoplastic Agents, Phytogenic; Disease Progression; Etoposide; Fatal Outcome; Female; Hodgkin Disease; Humans; Lymphohistiocytosis, Hemophagocytic; Middle Aged; Treatment Failure	2015
Cytomegalovirus Pneumonia after Anti-CC-chemokine Receptor 4 Monoclonal Antibody (Mogamulizumab) Therapy in an Angioimmunoblastic T-cell Lymphoma Patient. Internal medicine (Tokyo, Japan), 2016, Volume: 55, Issue:6 Topics: Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cisplatin; Cyclophosphamide; Cytarabine; Cytomegalovirus Infections; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Humans; Immunoblastic Lymphadenopathy; Lymphoma, T-Cell; Male; Methylprednisolone; Middle Aged; Pneumonia, Viral; Prednisone; Receptors, CCR4; Vincristine	2016
Clinical impact of post-progression survival on overall survival in elderly patients with extensive disease small-cell lung cancer. Thoracic cancer, 2016, Volume: 7, Issue:6 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease Progression; Disease-Free Survival; Etoposide; Female; Humans; Lung Neoplasms; Male; Small Cell Lung Carcinoma; Treatment Outcome	2016
Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma. International journal of radiation oncology, biology, physics, 2017, 01-01, Volume: 97, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Leucovorin; Liver; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Methotrexate; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Prednisone; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Recurrence; Rituximab; Statistics, Nonparametric; Vincristine; Young Adult	2017
Mathematical optimisation of the cisplatin plus etoposide combination for managing extensive-stage small-cell lung cancer patients. British journal of cancer, 2017, Volume: 116, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Calibration; Cisplatin; Disease Progression; Drug Dosage Calculations; Etoposide; Humans; Lung Neoplasms; Models, Theoretical; Neoplasm Staging; Small Cell Lung Carcinoma; Treatment Outcome; Tumor Burden	2017
Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: A feasibility of S-1. Respiratory investigation, 2017, Volume: 55, Issue:2 Topics: Acute-Phase Reaction; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Drug Combinations; Etoposide; Feasibility Studies; Female; Humans; Incidence; Lung Diseases, Interstitial; Lung Neoplasms; Male; Middle Aged; Oxonic Acid; Paclitaxel; Respiratory Insufficiency; Retrospective Studies; Tegafur	2017
Systemic chemotherapy for adrenocortical carcinoma: comparative responses to conventional first-line therapies. Anti-cancer drugs, 2008, Volume: 19, Issue:6 Topics: Adrenocortical Carcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Etoposide; Female; Humans; Male; Middle Aged; Mitotane; Regression Analysis	2008
Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: outcome compared with conventional chemotherapy: a report from the Children's Oncology Group. Pediatric blood & cancer, 2008, Volume: 51, Issue:6 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bone Marrow Transplantation; Brain Neoplasms; Carboplatin; Carmustine; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Disease Progression; Etoposide; Female; Humans; Infant; Male; Myeloablative Agonists; Neoplasm Recurrence, Local; Prognosis; Salvage Therapy; Thiotepa; Transplantation, Autologous	2008
Obstructive jaundice in a patient with mycosis fungoides metastatic to the pancreas. EUS findings. JOP : Journal of the pancreas, 2008, Nov-03, Volume: 9, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Cholangiopancreatography, Endoscopic Retrograde; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Humans; Jaundice, Obstructive; Magnetic Resonance Imaging; Male; Middle Aged; Mycosis Fungoides; Pancreatic Neoplasms; Prednisone; Stents; Tomography, X-Ray Computed; Treatment Outcome; Vincristine	2008
Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma. Neurosurgery, 2008, Volume: 63, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Administration Routes; Drug Administration Schedule; Etoposide; Female; Hemangiopericytoma; Humans; Ifosfamide; Interferon-alpha; Kaplan-Meier Estimate; Liposomes; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Rare Diseases; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine	2008
Topotecan-carboplatin-etoposide combination as 1st line treatment in patients with small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2009, Volume: 66, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease Progression; Dose-Response Relationship, Drug; Drug Tolerance; Etoposide; Female; Humans; Lung Neoplasms; Male; Small Cell Lung Carcinoma; Topotecan; Treatment Outcome	2009
Prognostic factors in elderly patients with advanced non-small cell lung cancer treated with chemotherapy. Oncology, 2009, Volume: 76, Issue:5 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Deoxycytidine; Disease Progression; Etoposide; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Medical Records; Neoplasm Staging; Paclitaxel; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome; Vinblastine; Vinorelbine	2009
Pralatrexate-induced tumor cell apoptosis in the epidermis of a patient with HTLV-1 adult T-cell lymphoma/leukemia causing skin erosions. Blood, 2009, Jun-18, Volume: 113, Issue:25 Topics: Adult; Aminopterin; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biopsy; Cyclophosphamide; Diagnosis, Differential; Disease Progression; Doxorubicin; Drug Eruptions; Epidermis; Etoposide; Exanthema; Folic Acid Antagonists; Humans; Interferon alpha-2; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Prednisone; Recombinant Proteins; Vincristine; Zidovudine	2009
The occurrence of hyponatremia in SCLC and the influence on prognosis: a retrospective study of 453 patients treated in a single institution in a 10-year period. Lung cancer (Amsterdam, Netherlands), 2010, Volume: 68, Issue:1 Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Disease Progression; Etoposide; Female; Humans; Hyponatremia; Lung Neoplasms; Male; Neoplasm Staging; Plasma; Prognosis; Retrospective Studies; Sex Factors; Small Cell Lung Carcinoma; Sodium; Survival Analysis	2010
A case of extranodal NK/T-cell lymphoma, nasal type mimicking typical manifestations of adult-onset Still's disease (AOSD) with hemophagocytic syndrome: diagnostic consideration between malignant lymphoma without lymphadenopathy and AOSD. Modern rheumatology, 2009, Volume: 19, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Dexamethasone; Diagnosis, Differential; Disease Progression; Etoposide; Herpesvirus 4, Human; Humans; Ifosfamide; Lymph Nodes; Lymphatic Diseases; Lymphoma, Extranodal NK-T-Cell; Male; Radiography; Splenomegaly; Still's Disease, Adult-Onset; Treatment Outcome	2009
[Positron emission tomography as a tool for early prediction of therapy outcome in soft tissue sarcoma]. Deutsche medizinische Wochenschrift (1946), 2009, Volume: 134, Issue:39 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Young Adult	2009
Re: Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomized, double-blind, placebo-controlled trial. Journal of the National Cancer Institute, 2009, Dec-02, Volume: 101, Issue:23 Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease Progression; Etoposide; Humans; Incidence; Lung Neoplasms; Randomized Controlled Trials as Topic; Small Cell Lung Carcinoma; Thalidomide; Thromboembolism	2009
CCR9 mediates PI3K/AKT-dependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide. International journal of cancer, 2010, Nov-01, Volume: 127, Issue:9 Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Chemokines, CC; Disease Progression; Enzyme Activation; Etoposide; Humans; Male; Mice; Mice, Nude; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Receptors, CCR; Signal Transduction	2010
Antiangiogenic combination therapy after local radiotherapy with topotecan radiosensitizer improved quality of life for children with inoperable brainstem gliomas. Acta paediatrica (Oslo, Norway : 1992), 2011, Volume: 100, Issue:1 Topics: Adolescent; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Celecoxib; Child; Child, Preschool; Disease Progression; Etoposide; Glioma; Humans; Pilot Projects; Pyrazoles; Quality of Life; Radiation-Sensitizing Agents; Sulfonamides; Survival Analysis; Thalidomide; Topotecan; Treatment Outcome	2011
Does the addition of involved field radiotherapy to high-dose chemotherapy and stem cell transplantation improve outcomes for patients with relapsed/refractory Hodgkin lymphoma? International journal of radiation oncology, biology, physics, 2011, Sep-01, Volume: 81, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Case-Control Studies; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Radiotherapy; Secondary Prevention; Stem Cell Transplantation; Transplantation Conditioning; Treatment Outcome; Tumor Burden; Young Adult	2011
A study on nm23-H1 expression in diffuse large B-cell lymphoma that was treated with CyclOBEAP plus rituximab therapy. Annals of hematology, 2011, Volume: 90, Issue:2 Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Immunophenotyping; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; NM23 Nucleoside Diphosphate Kinases; Prednisolone; Prognosis; Rituximab; Vincristine; Young Adult	2011
Clinical effect of temozolomide-based chemotherapy in poorly differentiated endocrine carcinoma after progression on first-line chemotherapy. Cancer, 2011, Oct-15, Volume: 117, Issue:20 Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Capecitabine; Carcinoma, Neuroendocrine; Cisplatin; Dacarbazine; Deoxycytidine; Disease Progression; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Repair; DNA Repair Enzymes; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Promoter Regions, Genetic; Retrospective Studies; Salvage Therapy; Temozolomide; Treatment Outcome; Tumor Suppressor Proteins	2011
ICSBP promoter methylation in myelodysplastic syndromes and acute myeloid leukaemia. Leukemia, 2011, Volume: 25, Issue:7 Topics: Aged; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Caspase 7; Cell Line, Tumor; Chromosome Aberrations; Disease Progression; DNA Methylation; Etoposide; Female; Humans; Interferon Regulatory Factors; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Neoplasm Proteins; Promoter Regions, Genetic	2011
Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Jun-20, Volume: 29, Issue:18 Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Castleman Disease; Comorbidity; Databases, Factual; Disease Progression; Disease-Free Survival; Drug Therapy, Combination; Etoposide; Female; Herpesviridae Infections; Herpesvirus 8, Human; HIV Infections; Humans; Incidence; Kaplan-Meier Estimate; Lymphoma, AIDS-Related; Male; Middle Aged; Proportional Hazards Models; Rituximab; Survival Analysis; Treatment Outcome; Young Adult	2011
Allogeneic hematopoietic cell transplant for peripheral T-cell non-Hodgkin lymphoma results in long-term disease control. Leukemia & lymphoma, 2011, Volume: 52, Issue:8 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Cyclophosphamide; Disease Progression; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Radiotherapy; Recurrence; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Young Adult	2011
Etoposide, cisplatin-etoposide, methotrexate, actinomycin-D as primary treatment for management of very-high-risk gestational trophoblastic neoplasia. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2011, Volume: 115, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dactinomycin; Disease Progression; Etoposide; Female; Gestational Trophoblastic Disease; Humans; India; Liver Neoplasms; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Risk; Salvage Therapy; Survival Rate; Treatment Outcome; Young Adult	2011
Longitudinal changes in cardiac function after cisplatin-based chemotherapy for testicular cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:10 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Disease Progression; Echocardiography; Etoposide; Galectin 3; Heart Diseases; Humans; Longitudinal Studies; Male; Middle Aged; Natriuretic Peptide, Brain; Testicular Neoplasms; Ventricular Dysfunction, Left; Young Adult	2011
Chemotherapy: Advanced Hodgkin lymphoma--balancing toxicity and cure. Nature reviews. Clinical oncology, 2011, Sep-06, Volume: 8, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Consolidation Chemotherapy; Cyclophosphamide; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Induction Chemotherapy; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Remission Induction; Salvage Therapy; Treatment Outcome; Vinblastine; Vincristine	2011
Two escalated followed by six standard BEACOPP in advanced-stage high-risk classical Hodgkin lymphoma: high cure rates but increased risk of aseptic osteonecrosis. Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cyclophosphamide; Disease Progression; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Osteonecrosis; Practice Guidelines as Topic; Prednisone; Procarbazine; Retrospective Studies; Risk; Survival Analysis; Vincristine; Young Adult	2012
Chemotherapy: Hodgkin lymphoma--absence of evidence not evidence of absence! Nature reviews. Clinical oncology, 2011, Oct-04, Volume: 8, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Remission Induction; Research Design; Salvage Therapy; Treatment Outcome; Vinblastine; Vincristine	2011
Teratoid Wilms' tumor: case report of a rare variant that can mimic aggressive biology during chemotherapy. Journal of pediatric surgery, 2011, Volume: 46, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dactinomycin; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Ifosfamide; Infant; Kidney Neoplasms; Male; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Nephrectomy; Prognosis; Stromal Cells; Vincristine; Wilms Tumor	2011
Homonymous hemianopsia in a patient with Hodgkin's lymphoma in remission after BEACOPP chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Apr-20, Volume: 30, Issue:12 Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bleomycin; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hemianopsia; Hodgkin Disease; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Vincristine	2012
Ulceration of abdominal striae distensae (stretch marks) in a cancer patient. Archives of dermatology, 2012, Volume: 148, Issue:3 Topics: Abdominal Wall; Adult; Antibodies, Antinuclear; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biopsy; Brain Neoplasms; Dexamethasone; Disease Progression; Drug Eruptions; Drug Interactions; Elastin; Etoposide; Fatal Outcome; Glioblastoma; Humans; Male; Neoplasm Staging; Ribonucleoproteins; Skin; Skin Ulcer; Striae Distensae	2012
Total gross tumor volume is an independent prognostic factor in patients treated with selective nodal irradiation for stage I to III small cell lung cancer. International journal of radiation oncology, biology, physics, 2013, Apr-01, Volume: 85, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Chemoradiotherapy; Cranial Irradiation; Disease Progression; Esophagitis; Etoposide; Female; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Irradiation; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prognosis; Radionuclide Imaging; Radiotherapy Dosage; Severity of Illness Index; Small Cell Lung Carcinoma; Tumor Burden	2013
Primary central nervous system diffuse large B cell lymphoma transformed from orbital mucosa-associated lymphoid tissue lymphoma: complete response to combined intrathecal and systemic rituximab. Annals of hematology, 2013, Volume: 92, Issue:7 Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clarithromycin; Cranial Irradiation; Cyclophosphamide; Disease Progression; Etoposide; Humans; Immunophenotyping; Immunosuppressive Agents; Injections, Spinal; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Male; Meningeal Neoplasms; Methotrexate; Methylprednisolone Hemisuccinate; Orbital Neoplasms; Prednisolone; Remission Induction; Rituximab; Vincristine	2013
Thalidomide paradoxical effect on concomitant multiple myeloma and myelodysplasia. Leukemia & lymphoma, 2002, Volume: 43, Issue:6 Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cell Division; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Disease Progression; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neoplastic Stem Cells; Peripheral Blood Stem Cell Transplantation; Thalidomide; Vincristine	2002
Adverse outcomes in primary hemophagocytic lymphohistiocytosis. Journal of pediatric hematology/oncology, 2002, Volume: 24, Issue:7 Topics: Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Child; Child, Preschool; Disease Progression; Etoposide; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Infant; Leukocytosis; Male; Methylprednisolone; Survival Rate; Treatment Outcome	2002
Regression of refractory rhabdomyosarcoma after allogeneic stem-cell transplantation. Pediatric hematology and oncology, 2003, Volume: 20, Issue:2 Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Female; Graft vs Tumor Effect; Head and Neck Neoplasms; Humans; Ifosfamide; Immunosuppressive Agents; Neoplasm Recurrence, Local; Nimustine; Peripheral Blood Stem Cell Transplantation; Rhabdomyosarcoma; Transplantation Conditioning; Vincristine	2003
Intra-arterial carboplatin and intravenous etoposide for the treatment of metastatic brain tumors. Journal of neuro-oncology, 2003, Volume: 61, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Disease Progression; Etoposide; Female; Hematologic Diseases; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Maximum Tolerated Dose; Middle Aged; Survival Rate; Time Factors; Treatment Outcome	2003
Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, May-01, Volume: 21, Issue:9 Topics: Adolescent; Adrenal Cortex Hormones; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Child; Child, Preschool; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Infant; L-Lactate Dehydrogenase; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Prognosis; Sclerosis; Treatment Outcome	2003
Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma. Cancer, 2003, Sep-01, Volume: 98, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Disease Progression; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Retrospective Studies; Survival Analysis; Thymus Neoplasms; Treatment Outcome; Vincristine	2003
Pharmacokinetic study of cisplatin and infusional etoposide phosphate in advanced breast cancer with correlation of response to topoisomerase IIalpha expression. Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Oct-15, Volume: 9, Issue:13 Topics: Adult; Aged; Antigens, Neoplasm; Antineoplastic Agents; Breast Neoplasms; Cisplatin; Cohort Studies; Disease Progression; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Female; Humans; Immunohistochemistry; Infusions, Intravenous; Middle Aged; Neoplasm Metastasis; Organophosphorus Compounds; Receptors, Estrogen; Time Factors	2003
Sterically stabilized etoposide liposomes: evaluation of antimetastatic activity and its potentiation by combination with sterically stabilized pentoxifylline liposomes in mice. Cancer biotherapy & radiopharmaceuticals, 2003, Volume: 18, Issue:5 Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Etoposide; Female; Liposomes; Lung Neoplasms; Male; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasm Transplantation; Pentoxifylline	2003
Safety of rituximab therapy during the first trimester of pregnancy: a case history. European journal of haematology, 2004, Volume: 72, Issue:4 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cladribine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant, Newborn; Lymphoma, Follicular; Male; Methotrexate; Mitoguazone; Peripheral Blood Stem Cell Transplantation; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy Trimester, First; Remission Induction; Rituximab; Safety; Transplantation, Autologous; Vincristine	2004
Bifocal esophageal and rectal cancer palliatively treated with argon plasma coagulation. Surgical endoscopy, 2004, Volume: 18, Issue:2 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Argon; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease Progression; Doxorubicin; Esophageal Neoplasms; Etoposide; Fatal Outcome; Humans; Light Coagulation; Male; Microsurgery; Neoplasms, Second Primary; Palliative Care; Rectal Neoplasms	2004
Usefulness of collagen gel droplet embedded culture drug sensitivity testing in ovarian cancer. Oncology reports, 2004, Volume: 12, Issue:2 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Culture Techniques; Cell Line, Tumor; Chemotherapy, Adjuvant; Cisplatin; Clinical Laboratory Techniques; Collagen; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Gels; Humans; Irinotecan; Middle Aged; Ovarian Neoplasms; Paclitaxel; Pharmaceutical Preparations; Recurrence; Remission Induction; Sensitivity and Specificity; Time Factors; Treatment Outcome	2004
Atypical teratoid/rhabdoid tumour with leptomeningeal dissemination in an adult. Acta neurochirurgica, 2004, Volume: 146, Issue:9 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Cisplatin; Combined Modality Therapy; Disease Progression; Etoposide; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Methotrexate; Neoplasm Invasiveness; Rhabdoid Tumor; Teratoma	2004
The effects of IL-2, IL-6 and IL-10 levels on prognosis in patients with aggressive Non-Hodgkin's Lymphoma (NHL). Journal of experimental & clinical cancer research : CR, 2004, Volume: 23, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Follow-Up Studies; Humans; Interleukin-10; Interleukin-2; Interleukin-6; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Prednisone; Prognosis; Regression Analysis; Time Factors; Treatment Outcome; Vincristine	2004
ESHAP for primary cutaneous T-cell lymphomas: efficacy and tolerance in 11 patients. The hematology journal : the official journal of the European Haematology Association, 2005, Volume: 5, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Cisplatin; Cytarabine; Disease Progression; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, T-Cell, Cutaneous; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Skin Neoplasms; Time Factors; Treatment Outcome	2005
Colonic T-cell leukemia mimicking colon carcinoma. American journal of surgery, 2005, Volume: 189, Issue:2 Topics: Aged; Antineoplastic Agents, Phytogenic; Carcinoma; Colectomy; Colonic Neoplasms; Diagnosis, Differential; Disease Progression; Etoposide; Humans; Leukemia, T-Cell; Male	2005
Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, May-01, Volume: 23, Issue:13 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Disease Progression; Etoposide; Humans; Lung Neoplasms; Neoplasm Staging; Prognosis; Retrospective Studies; Time Factors	2005
Extra nodal NK/T-cell lymphoma nasal type that responded to DeVIC combination chemotherapy. The Journal of dermatology, 2005, Volume: 32, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplatin; Combined Modality Therapy; Dexamethasone; Disease Progression; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Immunohistochemistry; Killer Cells, Natural; Lymphoma, T-Cell, Peripheral; Neoplasm Invasiveness; Neoplasm Staging; Radiotherapy, Adjuvant; Skin Neoplasms	2005
Front-line doublets in advanced non-small cell lung cancer: The golden age for second line chemotherapy. Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Docetaxel; Etoposide; Female; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Paclitaxel; Pemetrexed; Survival Rate; Taxoids	2005
Is it reasonable to consider second-line chemotherapy in patients with hormone-refractory prostate cancer? Oncology reports, 2005, Volume: 14, Issue:4 Topics: Aged; Androgen Antagonists; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Dexamethasone; Disease Progression; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Hormones; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Thrombocytopenia; Time Factors; Treatment Outcome	2005
Acute myeloid leukemia with near-triploid karyotype and extramedullary involvement of mediastinum. Bone marrow transplantation, 2005, Volume: 36, Issue:12 Topics: Adult; Antineoplastic Agents; Bone Marrow Cells; Central Nervous System; Cytarabine; Disease Progression; Etoposide; Humans; Idarubicin; Karyotyping; Leukemia, Myeloid, Acute; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Mediastinum; Polyploidy; Prognosis; Stem Cell Transplantation; Tomography, X-Ray Computed	2005
Tumor-derived p53 mutants induce NF-kappaB2 gene expression. Molecular and cellular biology, 2005, Volume: 25, Issue:22 Topics: Adenoviridae; Bromodeoxyuridine; Cell Line, Tumor; Cell Nucleus; Cloning, Molecular; Disease Progression; DNA, Complementary; Etoposide; Exons; Gene Expression Regulation, Neoplastic; Genetic Vectors; Humans; Mutation; NF-kappa B; NF-kappa B p52 Subunit; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction; RNA; RNA, Small Interfering; Transcription, Genetic; Transcriptional Activation; Transfection; Tumor Suppressor Protein p53; Up-Regulation	2005
One cycle of bleomycin, etoposide and cisplatin plus two cycles of etopeside and cisplatin chemotherapy in selected patients with low-volume stage II nonseminomatous germ cell tumor of the testis. Urologia internationalis, 2005, Volume: 75, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Diagnosis, Differential; Disease Progression; Etoposide; Follow-Up Studies; Humans; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Seminoma; Testicular Neoplasms; Tomography, X-Ray Computed; Treatment Outcome	2005
Similar response rates and superior early progression-free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine, etoposide, cytarabine, and melphalan salvage therapy prior to autologous stem cell transplantation Cancer, 2006, Jan-15, Volume: 106, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cytarabine; Deoxycytidine; Dexamethasone; Disease Progression; Disease-Free Survival; Etoposide; Female; Gemcitabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Melphalan; Middle Aged; Prognosis; Recurrence; Retrospective Studies; Salvage Therapy; Treatment Outcome	2006
Prognostic factors in pleuro-pulmonary blastoma. Pediatric blood & cancer, 2007, Volume: 48, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasm Staging; Pleural Neoplasms; Pneumonectomy; Prognosis; Pulmonary Blastoma; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Second-Look Surgery; Treatment Outcome; Vincristine	2007
Three cases of renal relapse after allogeneic hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia. Haematologica, 2006, Volume: 91, Issue:5 Suppl Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Dendritic Cells; Disease Progression; Etoposide; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy; Kidney; Leukemic Infiltration; Leukocyte Transfusion; Magnetic Resonance Imaging; Male; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiation Protection; Recurrence; Salvage Therapy; Tomography, X-Ray Computed; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation	2006
High dose chemotherapy with bone marrow or peripheral stem cell rescue is an effective treatment option for patients with relapsed or progressive Ewing's sarcoma family of tumours. Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Busulfan; Combined Modality Therapy; Disease Progression; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Neoplasm Recurrence, Local; Sarcoma, Ewing; Treatment Outcome	2006
False-positive restaging PET scans involving the spleen in two patients with aggressive non-Hodgkin lymphoma. Clinical nuclear medicine, 2006, Volume: 31, Issue:7 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Burkitt Lymphoma; Carboplatin; Cyclophosphamide; Dexamethasone; Disease Progression; Doxorubicin; Etoposide; False Positive Reactions; Humans; Ifosfamide; Laparoscopy; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Necrosis; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Remission Induction; Rituximab; Salvage Therapy; Spleen; Splenectomy; Tomography, X-Ray Computed; Unnecessary Procedures; Vincristine	2006
Successful chemotherapy and 90Y-DOTATOC in a patient with mediastinal highly aggressive neuroendocrine carcinoma. Acta oncologica (Stockholm, Sweden), 2006, Volume: 45, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Disease Progression; Etoposide; Female; Humans; Mediastinal Neoplasms; Middle Aged; Neoplasms, Unknown Primary; Octreotide; Remission Induction; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome	2006
Late response to radiochemotherapy in pediatric glioblastoma: report on two patients treated according to HIT-GBM protocols. Pediatric hematology and oncology, 2006, Volume: 23, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Disease Progression; Etoposide; Fatal Outcome; Follow-Up Studies; Glioblastoma; Humans; Ifosfamide; Male; Randomized Controlled Trials as Topic; Remission Induction; Supratentorial Neoplasms; Time Factors; Treatment Outcome; Vincristine	2006
Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma. Pediatric blood & cancer, 2008, Volume: 50, Issue:3 Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biliary Atresia; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunocompromised Host; Immunosuppressive Agents; Liver Transplantation; Lymphoma, T-Cell, Peripheral; Lymphoproliferative Disorders; Melphalan; Mesna; Postoperative Complications; Prednisone; Radiotherapy, Adjuvant; Transplantation, Autologous; Vidarabine; Vincristine	2008
Association between anemia arising during therapy and outcomes of chemoradiation for limited small-cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2006, Volume: 1, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Drug Therapy, Combination; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Ontario; Prevalence; Retrospective Studies; Survival Rate; Treatment Outcome	2006
[Our experiences in treating patients with Hodgkin disease in the last decade]. Orvosi hetilap, 2007, Apr-15, Volume: 148, Issue:15 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cyclophosphamide; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Hungary; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine	2007
Collagen gel matrix assay as an in vitro chemosensitivity test for malignant astrocytic tumors. International journal of clinical oncology, 2007, Volume: 12, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Astrocytoma; Carboplatin; Central Nervous System Neoplasms; Cisplatin; Collagen; Disease Progression; Disease-Free Survival; Drug Screening Assays, Antitumor; Etoposide; Female; Fibrin Foam; Follow-Up Studies; Glioblastoma; Humans; Japan; Karnofsky Performance Status; Male; Middle Aged; Nimustine; Sensitivity and Specificity; Survival Analysis; Tissue Adhesives; Treatment Outcome; Tumor Burden; Tumor Cells, Cultured	2007
[Early relapse of Burkitt's lymphoma with t(8;14) and t(14;18) after rituximab-combined CODOX-M and IVAC therapy]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2007, Volume: 48, Issue:4 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 8; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Methotrexate; Recurrence; Remission Induction; Rituximab; Translocation, Genetic; Vincristine	2007
Thalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplant. American journal of hematology, 2007, Volume: 82, Issue:10 Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Histiocytes; Humans; Middle Aged; Prednisone; Retroperitoneal Neoplasms; Sarcoma; Thalidomide; Vincristine	2007
Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Sep-01, Volume: 25, Issue:25 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Disease Progression; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Mechlorethamine; Mediastinal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Recurrence; Retrospective Studies; Treatment Outcome; Vinblastine; Vincristine	2007
[Long-term follow-up of patients with suprasellar germinomas]. Medizinische Klinik (Munich, Germany : 1983), 2007, Oct-15, Volume: 102, Issue:10 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Diabetes Insipidus; Disease Progression; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Hypopituitarism; Ifosfamide; Male; Neoplasm Recurrence, Local; Paraneoplastic Endocrine Syndromes; Pituitary Irradiation; Pituitary Neoplasms; Survival Rate	2007
[Chemotherapy of advanced non small cell lung cancer: effect on survival and symptoms affecting quality of life]. Pneumonologia i alergologia polska, 2007, Volume: 75, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Poland; Quality of Life; Retrospective Studies; Survival Analysis; Treatment Outcome; Vinblastine	2007
High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Jan-10, Volume: 26, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Disease Progression; Etoposide; Female; Humans; Immunoblastic Lymphadenopathy; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Remission Induction; Retrospective Studies; Stem Cell Transplantation; Survival Analysis; Transplantation Conditioning; Treatment Outcome	2008
High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system. Cancer, 2008, Apr-15, Volume: 112, Issue:8 Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Cisplatin; Cohort Studies; Disease Progression; Etoposide; Female; Follow-Up Studies; Humans; Lomustine; Male; Medulloblastoma; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Procarbazine; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Thiotepa; Transplantation, Autologous	2008
Long-term outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:7 Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Disease Progression; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Melphalan; Middle Aged; Multivariate Analysis; Myelodysplastic Syndromes; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Time Factors; Transplantation, Autologous; Treatment Outcome	2008
Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie Innnovative nei linfomi survey. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Jul-01, Volume: 26, Issue:19 Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Disease Progression; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Italy; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Methotrexate; Middle Aged; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Factors; Rituximab; Survival Rate; Thiotepa; Transplantation, Autologous; Treatment Outcome	2008
A metastatic neuroendocrine anaplastic small cell tumor in a patient with multiple endocrine neoplasia type 1 syndrome. Assessment of disease status and response to doxorubicin, cyclophosphamide, etoposide chemotherapy through scintigraphic imaging with 1 Cancer, 1994, Oct-15, Volume: 74, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Indium Radioisotopes; Middle Aged; Multiple Endocrine Neoplasia Type 1; Radionuclide Imaging; Salvage Therapy; Somatostatin	1994
Double mutations of the N-ras gene in a patient with acute myelomonocytic leukemia. International journal of hematology, 1995, Volume: 61, Issue:4 Topics: Aclarubicin; Alleles; Antineoplastic Combined Chemotherapy Protocols; Chromosome Deletion; Chromosomes, Human, Pair 12; Chromosomes, Human, Pair 9; Codon; Cytarabine; Daunorubicin; Disease Progression; Doxorubicin; Etoposide; Fatal Outcome; Genes, ras; Genetic Vectors; Humans; Karyotyping; Leukemia, Myelomonocytic, Acute; Male; Mercaptopurine; Middle Aged; Mitoxantrone; Point Mutation; Prednisolone; Vinblastine; Vincristine	1995
Idarubicin in combination with cytarabine and VP-16 in the treatment of post myelodysplastic syndrome acute myeloblastic leukemia (MDS-AML). Leukemia & lymphoma, 1995, Volume: 19, Issue:5-6 Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease Progression; Disease-Free Survival; Etoposide; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Remission Induction	1995
Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumors. Journal of surgical oncology, 1996, Volume: 61, Issue:3 Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Dactinomycin; Disease Progression; Etoposide; Follow-Up Studies; Germinoma; Humans; Lymph Node Excision; Male; Middle Aged; Neoplasm Staging; Retroperitoneal Space; Retrospective Studies; Testicular Neoplasms; Treatment Outcome; Vinblastine	1996
Exacerbation of hepatitis in hepatitis B carriers following chemotherapy for haematological malignancies. Annals of the Academy of Medicine, Singapore, 1996, Volume: 25, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carrier State; Chronic Disease; Cyclophosphamide; Cytarabine; Daunorubicin; Disease Progression; Doxorubicin; Etoposide; Female; Hepatic Encephalopathy; Hepatitis B; Humans; Leucovorin; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine	1996
Salvage treatment after failure or relapse following initial chemotherapy for follicular non-Hodgkin's lymphoma. Leukemia & lymphoma, 1997, Volume: 24, Issue:3-4 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Life Tables; Lymphoma, Follicular; Male; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Procarbazine; Prognosis; Proportional Hazards Models; Remission Induction; Salvage Therapy; Survival Analysis; Vincristine	1997
High-dose chemotherapy and stem-cell rescue in the treatment of high-risk breast cancer: prognostic indicators of progression-free and overall survival. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:8 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Prognosis; Risk Factors; Survival Rate	1997
Radiotherapy after chemotherapy for metastatic seminoma--a diminishing role. MRC Testicular Tumour Working Party. European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:6 Topics: Abdominal Neoplasms; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Disease Progression; Etoposide; Humans; Male; Middle Aged; Radiotherapy, Adjuvant; Retrospective Studies; Seminoma; Survival Rate; Testicular Neoplasms; Treatment Outcome	1997
Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Etoposide; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Thrombocytopenia; Transplantation, Autologous; Vincristine	1998
Drug resistance in human neuroblastoma cell lines correlates with clinical therapy. European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:12 Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Humans; Melphalan; Neuroblastoma; Tumor Cells, Cultured	1997
Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphoma: a pilot study of the BOMES protocol. Cancer, 1998, May-15, Volume: 82, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Disease Progression; Etoposide; Female; Humans; Lymphoma, AIDS-Related; Male; Methotrexate; Methylprednisolone Hemisuccinate; Middle Aged; Pilot Projects; Prospective Studies; Survival Rate; Treatment Outcome; Vincristine	1998
p53 gene mutation in the bone-marrow of a patient with diffuse mixed cell type lymphoma at diagnosis predicting eventual progression to large cell lymphoma. Leukemia & lymphoma, 1998, Volume: 29, Issue:3-4 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cisplatin; Dexamethasone; Disease Progression; Etoposide; Fatal Outcome; Genes, p53; Genetic Markers; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mutation; Sequence Analysis, DNA	1998
Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy. Cancer research, 1998, Dec-01, Volume: 58, Issue:23 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Cisplatin; Disease Progression; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Gene Amplification; Genes, myc; Humans; Kinetics; Neuroblastoma; Phenotype; Polymerase Chain Reaction; Time Factors; Tumor Cells, Cultured	1998
A limited role for VEEP (vincristine, etoposide, epirubicin, prednisolone) chemotherapy in childhood Hodgkin's disease. European journal of cancer (Oxford, England : 1990), 1998, Volume: 34, Issue:13 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cohort Studies; Disease Progression; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Prednisolone; Recurrence; Salvage Therapy; Vincristine	1998
Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study. Bone marrow transplantation, 1999, Volume: 23, Issue:3 Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents; Bone Marrow Purging; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease Progression; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Length of Stay; Leukemia, Myeloid; Male; Mechlorethamine; Middle Aged; Mitoxantrone; Neoplasms, Second Primary; Neoplastic Stem Cells; Pilot Projects; Platelet Transfusion; Recurrence; Remission Induction; Risk; Salvage Therapy; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vidarabine	1999
Long-term molecular remission in promyelocytic transformation of myeloproliferative disease. Leukemia, 1999, Volume: 13, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cytarabine; Daunorubicin; Disease Progression; Etoposide; Female; Humans; Idarubicin; Karyotyping; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Proteins; Oncogene Proteins, Fusion; Polycythemia Vera; Preleukemia; Prognosis; Remission Induction; Thrombocythemia, Essential; Thrombophilia; Translocation, Genetic; Tretinoin	1999
ChlVPP/ABV-VP16 hybrid regimen for advanced Hodgkin's disease: a study in 36 patients. Leukemia & lymphoma, 1999, Volume: 33, Issue:3-4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisolone; Procarbazine; Retrospective Studies; Survival Analysis; Time Factors; Vinblastine	1999
Diffuse large-cell lymphoma of the testis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Prospective Studies; Recurrence; Retrospective Studies; Salvage Therapy; Testicular Neoplasms; Treatment Outcome; Vincristine	1999
Hematologic toxic reaction to radiation therapy adjuvant to autologous peripheral blood stem cell transplantation for recurrent or refractory Hodgkin disease. Radiology, 2000, Volume: 214, Issue:2 Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Disease Progression; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Neoplasm Recurrence, Local; Platelet Count; Radiation Injuries; Radiotherapy, Adjuvant; Retrospective Studies; Thrombocytopenia; Transplantation, Autologous	2000
Long-term follow-up of advanced-stage low-grade lymphoma patients treated upfront with high-dose sequential chemotherapy and autograft. Leukemia, 2000, Volume: 14, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Mitoxantrone; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine	2000
High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2000, Volume: 6, Issue:3A Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Carmustine; Central Nervous System; Central Nervous System Neoplasms; Cognition Disorders; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease Progression; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelitis, Transverse; Neoplasm Invasiveness; Quality of Life; Radiation Injuries; Survival Analysis; Survival Rate; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation	2000
Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma. European journal of haematology, 2000, Volume: 65, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Carmustine; Cataract; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Infections; Life Tables; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Prognosis; Remission Induction; Retrospective Studies; Survival Analysis; Sweden; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Whole-Body Irradiation	2000
Feasibility and toxicity of high-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly patients (>/=60 years) with non-Hodgkin's lymphoma: comparison with patients <60 years treated within the same protocol. Bone marrow transplantation, 2000, Volume: 26, Issue:7 Topics: Adolescent; Adult; Age Factors; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Disease Progression; Etoposide; Female; Graft Survival; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Infections; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Podophyllotoxin; Survival Rate; Time Factors; Transplantation Conditioning	2000
Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2000, Volume: 6, Issue:5A Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Purging; Cardiomyopathies; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Cyclophosphamide; Cystitis; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Infections; Leucovorin; Life Tables; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Mitoxantrone; Pilot Projects; Salvage Therapy; Survival Analysis; Survival Rate; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine	2000
Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy. Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Disease Progression; Etoposide; Fatal Outcome; Female; Headache; Humans; Immunologic Factors; Injections, Spinal; Interferon alpha-2; Interferon-alpha; Mast-Cell Sarcoma; Nausea; Neoplasm Recurrence, Local; Palliative Care; Papilledema; Parietal Lobe; Prednisolone; Radioisotope Teletherapy; Recombinant Proteins; Remission Induction; Supratentorial Neoplasms; Temporal Lobe; Treatment Failure; Vomiting	2001
Tumor lysis syndrome in an infant with Langerhans cell histiocytosis successfully treated using continuous arteriovenous hemofiltration. Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:2 Topics: Acute Kidney Injury; Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Blood Transfusion; Combined Modality Therapy; Disease Progression; Etoposide; Fatal Outcome; Female; Fluid Therapy; Hemofiltration; Histiocytosis, Langerhans-Cell; Humans; Infant; L-Lactate Dehydrogenase; Lymph Nodes; Mercaptopurine; Multiple Organ Failure; Neck; Orbital Diseases; Prednisolone; Sodium Bicarbonate; Temporal Bone; Tumor Lysis Syndrome; Uric Acid; Vinblastine; Vincristine	2001
Selection of candidates for oral etoposide salvage chemotherapy in heavily pretreated breast cancer patients. Anti-cancer drugs, 2001, Volume: 12, Issue:3 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Disease Progression; Etoposide; Female; Humans; Middle Aged; Patient Selection; Salvage Therapy; Survival Analysis; Treatment Outcome	2001
Myeloablative chemotherapy for recurrent aggressive oligodendroglioma. Neuro-oncology, 2000, Volume: 2, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Transplantation; Brain Diseases; Brain Neoplasms; Cachexia; Cerebral Hemorrhage; Cisplatin; Disease Progression; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Karnofsky Performance Status; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Survival Analysis; Survival Rate; Thiotepa; Treatment Failure; Vincristine	2000
A case of repetitive intrapleural cancer chemotherapy using INFUSE-A-PORT for malignant mesothelioma. The Thoracic and cardiovascular surgeon, 2001, Volume: 49, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Catheters, Indwelling; Chemotherapy, Cancer, Regional Perfusion; Disease Progression; Drug Administration Schedule; Etoposide; Fluorouracil; Humans; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Radiography; Retreatment	2001
Serum creatine kinase levels parallel the clinical course for rhabdomyomatous Wilms tumor. American journal of clinical pathology, 2001, Volume: 116, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Creatine Kinase; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Infant; Kidney Neoplasms; Mesna; Neoplasm Recurrence, Local; Nephrectomy; Reference Standards; Rhabdomyoma; Vincristine; Wilms Tumor	2001
Neuroblastoma. Saudi medical journal, 2001, Volume: 22, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Infant; Male; Neoplasm Staging; Neuroblastoma; Retrospective Studies; Second-Look Surgery; Survival Rate; Treatment Outcome; Vincristine	2001
Experience in treatment of metastatic pulmonary carcinoid tumors. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Cisplatin; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Prognosis; Retrospective Studies; Somatostatin; Streptozocin; Survival Analysis	2001
Choriocarcinoma of the gallbladder: treated with cisplatin-based chemotherapy. Medical oncology (Northwood, London, England), 2001, Volume: 18, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Disease Progression; Etoposide; Fatal Outcome; Female; Gallbladder Neoplasms; Humans; Immunohistochemistry; Middle Aged	2001
Extragonadal seminoma after renal transplantation and immunosuppression; treatment in the presence of renal dysfunction: a case report and literature review. Medical oncology (Northwood, London, England), 2001, Volume: 18, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chromosome Aberrations; Chromosomes, Human, Pair 12; Diagnosis, Differential; Disease Progression; Etoposide; Fatal Outcome; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Paclitaxel; Pelvic Neoplasms; Seminoma	2001
Influence of phenytoin on the disposition of irinotecan: a case report. Journal of pediatric hematology/oncology, 2002, Volume: 24, Issue:2 Topics: Adolescent; Anticonvulsants; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Brain Neoplasms; Camptothecin; Carboplatin; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dexamethasone; Disease Progression; Drug Interactions; Enzyme Induction; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Irinotecan; Male; Melphalan; Mixed Function Oxygenases; Neoplasm Recurrence, Local; Ondansetron; Phenobarbital; Phenytoin; Pineal Gland; Pinealoma; Prodrugs; Salvage Therapy; Seizures	2002
Epstein-Barr virus-associated lymphoma in a child undergoing an autologous stem cell rescue. Journal of pediatric hematology/oncology, 2002, Volume: 24, Issue:2 Topics: Acyclovir; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carboplatin; Central Nervous System Neoplasms; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Epstein-Barr Virus Infections; Etoposide; Eye Enucleation; Eye Neoplasms; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Immunosuppressive Agents; Immunotherapy; Lymphoma, Large B-Cell, Diffuse; Male; Meningeal Neoplasms; Methylprednisolone; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Optic Nerve Neoplasms; Radiotherapy, Adjuvant; Retinoblastoma; Rituximab; Thiotepa; Vincristine	2002